# EDGAR Filing Document

**Accession Number:** 0001378872
**File Stem:** 0001752724-23-017850
**Filing Date:** 2023-1
**Character Count:** 178146
**Document Hash:** 10639c271be6a7c3be6664227aea20f3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-23-017850.hdr.sgml**: 20230130

**ACCESSION NUMBER**: 0001752724-23-017850

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20221130

**FILED AS OF DATE**: 20230130

**DATE AS OF CHANGE**: 20230130

**PERIOD START**: 20230831

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Invesco Exchange-Traded Fund Trust II
- **CENTRAL INDEX KEY:** 0001378872
- **IRS NUMBER:** 000000000
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-21977
- **FILM NUMBER:** 23566566

**BUSINESS ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515
- **BUSINESS PHONE:** 800-983-0903

**MAIL ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PowerShares Exchange-Traded Fund Trust II
- **DATE OF NAME CHANGE:** 20070919

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PowerShares Global Exchange-Traded Fund Trust
- **DATE OF NAME CHANGE:** 20061023

## Series and Classes Contracts Data

### Invesco NASDAQ Future Gen 200 ETF (Series ID: S000077288)

| Class ID   | Class Name                        | Ticker Symbol   |
|:---|:---|:---|
| C000237581 | Invesco NASDAQ Future Gen 200 ETF | QQQS            |

## Nport-Ex

Schedule of Investments<sup>(a)</sup><br>

### Invesco ESG NASDAQ 100 ETF (QQMG)
November 30, 2022

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Common Stocks & Other Equity Interests-99.91%** | **Common Stocks & Other Equity Interests-99.91%** | **Common Stocks & Other Equity Interests-99.91%** |
| **Communication Services-12.94%** | **Communication Services-12.94%** | **Communication Services-12.94%** |
| Activision Blizzard, Inc.<br>| &nbsp;&nbsp;&nbsp;795 | &nbsp;&nbsp;&nbsp;&nbsp;$58791 |
| Alphabet, Inc., Class A<sup>(b)</sup><br>| 2772 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;279944 |
| Alphabet, Inc., Class C<sup>(b)</sup><br>| 2849 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;289031 |
| Baidu, Inc., ADR (China)<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;169 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18353 |
| Charter Communications, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;104 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;40694 |
| Comcast Corp., Class A<br>| 3237 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;118604 |
| Electronic Arts, Inc.<br>| &nbsp;&nbsp;&nbsp;398 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52051 |
| Match Group, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;277 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14005 |
| Meta Platforms, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;741 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;87512 |
| NetEase, Inc., ADR (China)<br>| &nbsp;&nbsp;&nbsp;196 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13940 |
| Netflix, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;510 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;155820 |
| Sirius XM Holdings, Inc.<sup>(c)</sup><br>| 4358 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28284 |
| T-Mobile US, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;843 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;127681 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;1284710 |
| **Consumer Discretionary-10.46%** | **Consumer Discretionary-10.46%** | **Consumer Discretionary-10.46%** |
| Airbnb, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;279 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28497 |
| Amazon.com, Inc.<sup>(b)</sup><br>| 2886 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;278615 |
| Booking Holdings, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;34 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;70701 |
| Dollar Tree, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;269 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;40428 |
| eBay, Inc.<br>| &nbsp;&nbsp;&nbsp;607 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27582 |
| JD.com, Inc., ADR (China)<br>| &nbsp;&nbsp;&nbsp;298 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17040 |
| Lucid Group, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;678 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6875 |
| lululemon athletica, inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;141 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;53624 |
| Marriott International, Inc., Class A<br>| &nbsp;&nbsp;&nbsp;284 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;46959 |
| MercadoLibre, Inc. (Brazil)<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;44 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;40963 |
| O'Reilly Automotive, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;83 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;71757 |
| Pinduoduo, Inc., ADR (China)<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;244 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20018 |
| Ross Stores, Inc.<br>| &nbsp;&nbsp;&nbsp;406 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;47774 |
| Starbucks Corp.<br>| &nbsp;&nbsp;&nbsp;840 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;85848 |
| Tesla, Inc.<sup>(b)</sup><br>| 1039 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;202293 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;1038974 |
| **Consumer Staples-6.87%** | **Consumer Staples-6.87%** | **Consumer Staples-6.87%** |
| Costco Wholesale Corp.<br>| &nbsp;&nbsp;&nbsp;339 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;182806 |
| Keurig Dr Pepper, Inc.<br>| 1285 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;49691 |
| Kraft Heinz Co. (The)<br>| &nbsp;&nbsp;&nbsp;278 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10939 |
| Mondelez International, Inc., Class A<br>| 1072 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;72478 |
| Monster Beverage Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;304 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31269 |
| PepsiCo, Inc.<br>| 1606 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;297929 |
| Walgreens Boots Alliance, Inc.<br>| &nbsp;&nbsp;&nbsp;905 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;37558 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;682670 |
| **Health Care-7.15%** | **Health Care-7.15%** | **Health Care-7.15%** |
| Align Technology, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;78 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15339 |
| Amgen, Inc.<br>| &nbsp;&nbsp;&nbsp;464 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;132890 |
| AstraZeneca PLC, ADR (United Kingdom)<br>| &nbsp;&nbsp;&nbsp;508 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34529 |
| Biogen, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;133 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;40588 |
| DexCom, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;308 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;35814 |
| Gilead Sciences, Inc.<br>| 1083 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;95120 |
| IDEXX Laboratories, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;77 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;32792 |
| Illumina, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;219 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;47759 |
| Intuitive Surgical, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;280 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;75709 |
| Moderna, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;192 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;33775 |
| Regeneron Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;113 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;84942 |
| Seagen, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;115 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13960 |
| Vertex Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;211 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;66760 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;709977 |
| **Industrials-2.53%** | **Industrials-2.53%** | **Industrials-2.53%** |
| Cintas Corp.<br>| &nbsp;&nbsp;&nbsp;104 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;48025 |
| Copart, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;502 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;33413 |
| CSX Corp.<br>| 2057 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;67243 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Industrials-(continued)** | **Industrials-(continued)** | **Industrials-(continued)** |
| Fastenal Co.<br>| &nbsp;&nbsp;&nbsp;377 | &nbsp;&nbsp;&nbsp;&nbsp;$19419 |
| Old Dominion Freight Line, Inc.<br>| &nbsp;&nbsp;&nbsp;111 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;33590 |
| PACCAR, Inc.<br>| &nbsp;&nbsp;&nbsp;205 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21712 |
| Verisk Analytics, Inc.<br>| &nbsp;&nbsp;&nbsp;151 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27740 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;251142 |
| **Information Technology-59.96%** | **Information Technology-59.96%** | **Information Technology-59.96%** |
| Adobe, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;624 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;215236 |
| Advanced Micro Devices, Inc.<sup>(b)</sup><br>| 1551 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;120404 |
| ANSYS, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;113 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28736 |
| Apple, Inc.<br>| 8867 | &nbsp;&nbsp;&nbsp;&nbsp;1312582 |
| Applied Materials, Inc.<br>| 1187 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;130095 |
| ASML Holding N.V., New York Shares (Netherlands)<br>| &nbsp;&nbsp;&nbsp;121 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;73582 |
| Atlassian Corp., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;156 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20522 |
| Autodesk, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;249 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;50286 |
| Automatic Data Processing, Inc.<br>| &nbsp;&nbsp;&nbsp;522 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;137881 |
| Broadcom, Inc.<br>| &nbsp;&nbsp;&nbsp;345 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;190105 |
| Cadence Design Systems, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;366 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;62967 |
| Cisco Systems, Inc.<br>| 5593 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;278084 |
| Cognizant Technology Solutions Corp., Class A<br>| &nbsp;&nbsp;&nbsp;640 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;39814 |
| Crowdstrike Holdings, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;179 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21059 |
| Datadog, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;261 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19779 |
| DocuSign, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;207 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9743 |
| Fiserv, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;668 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;69712 |
| Fortinet, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;795 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;42262 |
| Intel Corp.<br>| 4529 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;136187 |
| Intuit, Inc.<br>| &nbsp;&nbsp;&nbsp;324 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;132059 |
| KLA Corp.<br>| &nbsp;&nbsp;&nbsp;158 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;62118 |
| Lam Research Corp.<br>| &nbsp;&nbsp;&nbsp;174 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;82194 |
| Marvell Technology, Inc.<br>| &nbsp;&nbsp;&nbsp;955 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;44427 |
| Microchip Technology, Inc.<br>| &nbsp;&nbsp;&nbsp;242 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19164 |
| Micron Technology, Inc.<br>| 1201 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;69238 |
| Microsoft Corp.<br>| 5332 | &nbsp;&nbsp;&nbsp;&nbsp;1360406 |
| NVIDIA Corp.<br>| 2711 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;458783 |
| NXP Semiconductors N.V. (China)<br>| &nbsp;&nbsp;&nbsp;233 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;40971 |
| Palo Alto Networks, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;372 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;63203 |
| Paychex, Inc.<br>| &nbsp;&nbsp;&nbsp;389 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;48248 |
| PayPal Holdings, Inc.<sup>(b)</sup><br>| 1347 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;105618 |
| QUALCOMM, Inc.<br>| 1272 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;160895 |
| Skyworks Solutions, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;92 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8797 |
| Splunk, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;174 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13516 |
| Synopsys, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;196 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;66550 |
| Texas Instruments, Inc.<br>| &nbsp;&nbsp;&nbsp;888 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;160248 |
| VeriSign, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;97 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19382 |
| Workday, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;261 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;43822 |
| Zoom Video Communications, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;253 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19084 |
| Zscaler, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;128 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17082 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;5954841 |
| &nbsp;&nbsp;&nbsp;Total Common Stocks & Other Equity Interests<br>(Cost $12,270,759) | &nbsp;&nbsp;&nbsp;Total Common Stocks & Other Equity Interests<br>(Cost $12,270,759) | &nbsp;&nbsp;9922314 |
| **Money Market Funds-0.01%** | **Money Market Funds-0.01%** | **Money Market Funds-0.01%** |
| Invesco Government & Agency Portfolio, Institutional Class, 3.73%<sup>(d)(e)</sup><br>(Cost $1,471)<br>| 1471 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1471 |
| TOTAL INVESTMENTS IN SECURITIES<br>(excluding investments purchased with cash collateral from securities on loan)-99.92%<br>(Cost $12,272,230) | TOTAL INVESTMENTS IN SECURITIES<br>(excluding investments purchased with cash collateral from securities on loan)-99.92%<br>(Cost $12,272,230) | &nbsp;&nbsp;9923785 |

---

See accompanying notes which are an integral part of this schedule.

------

### Invesco ESG NASDAQ 100 ETF (QQMG)—(continued)<br>
November 30, 2022

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Investments Purchased with Cash Collateral from Securities on Loan** | **Investments Purchased with Cash Collateral from Securities on Loan** | **Investments Purchased with Cash Collateral from Securities on Loan** |
| **Money Market Funds-0.36%** | **Money Market Funds-0.36%** | **Money Market Funds-0.36%** |
| Invesco Private Government Fund, 3.83%<sup>(d)(e)(f)</sup><br>| &nbsp;&nbsp;9738 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$9738 |
| Invesco Private Prime Fund, 4.15%<sup>(d)(e)(f)</sup><br>| 25907 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25912 |
| &nbsp;&nbsp;&nbsp;Total Investments Purchased with Cash Collateral from Securities on Loan<br>(Cost $35,645) | &nbsp;&nbsp;&nbsp;Total Investments Purchased with Cash Collateral from Securities on Loan<br>(Cost $35,645) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;35650 |
| TOTAL INVESTMENTS IN SECURITIES-100.28%<br>(Cost $12,307,875) | TOTAL INVESTMENTS IN SECURITIES-100.28%<br>(Cost $12,307,875) | &nbsp;&nbsp;9959435 |
| OTHER ASSETS LESS LIABILITIES-(0.28)% | OTHER ASSETS LESS LIABILITIES-(0.28)% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(27773) |
| NET ASSETS-100.00% | NET ASSETS-100.00% | $9931662 |

---

Investment Abbreviations: <br> ADR -American Depositary Receipt

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is the exclusive property and a service mark of MSCI Inc. and Standard & Poor's. |
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at November 30, 2022. |
| <sup>(d)</sup> | Affiliated issuer. The issuer and/or the Fund is a wholly-owned subsidiary of Invesco Ltd., or is affiliated by having an investment adviser that is under common control of Invesco Ltd. The table below shows the Fund's transactions in, and earnings from, its investments in affiliates for the three months ended November 30, 2022. |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;&nbsp;**Value<br> August 31, 2022** | &nbsp;&nbsp;&nbsp;**Purchases<br> at Cost** | &nbsp;&nbsp;&nbsp;**Proceeds<br> from Sales** | &nbsp;&nbsp;&nbsp;**Change in<br> Unrealized<br> Appreciation** | &nbsp;&nbsp;&nbsp;**Realized<br> Gain<br> (Loss)** | &nbsp;&nbsp;&nbsp;**Value<br> November 30, 2022** | &nbsp;&nbsp;&nbsp;**Dividend<br> Income** |
| &nbsp;&nbsp;**Investments in Affiliated Money Market Funds:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Invesco Government & Agency Portfolio, Institutional Class | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$30788 | &nbsp;&nbsp;&nbsp;$(29317) | &nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$1471 | &nbsp;&nbsp;&nbsp;$29 |
| &nbsp;&nbsp;**Investments Purchased with Cash Collateral from Securities on Loan:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Invesco Private Government Fund | &nbsp;&nbsp;&nbsp;&nbsp;20569 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;54361 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(65192) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9738 | &nbsp;&nbsp;&nbsp;&nbsp;141\* |
| &nbsp;&nbsp;Invesco Private Prime Fund | &nbsp;&nbsp;&nbsp;&nbsp;52891 | &nbsp;&nbsp;&nbsp;&nbsp;113151 | &nbsp;&nbsp;&nbsp;&nbsp;(140123) | &nbsp;&nbsp;&nbsp;&nbsp;5 | &nbsp;&nbsp;&nbsp;&nbsp;(12) | &nbsp;&nbsp;&nbsp;&nbsp;25912 | &nbsp;&nbsp;&nbsp;&nbsp;383\* |
| &nbsp;&nbsp;Total | &nbsp;&nbsp;&nbsp;$73460 | &nbsp;&nbsp;&nbsp;$198300 | &nbsp;&nbsp;&nbsp;$(234632) | &nbsp;&nbsp;&nbsp;$5 | &nbsp;&nbsp;&nbsp;$(12) | &nbsp;&nbsp;&nbsp;$37121 | &nbsp;&nbsp;&nbsp;$553 |

---

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of November 30, 2022. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup><br>

### Invesco ESG NASDAQ Next Gen 100 ETF (QQJG)
November 30, 2022

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Common Stocks & Other Equity Interests-99.96%** | **Common Stocks & Other Equity Interests-99.96%** | **Common Stocks & Other Equity Interests-99.96%** |
| **Communication Services-14.16%** | **Communication Services-14.16%** | **Communication Services-14.16%** |
| Bilibili, Inc., ADR (China)<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;152 | &nbsp;&nbsp;&nbsp;&nbsp;$2639 |
| DISH Network Corp., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;716 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11492 |
| Fox Corp., Class A<br>| 1080 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;35046 |
| Fox Corp., Class B<br>| &nbsp;&nbsp;&nbsp;855 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26095 |
| IAC, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;185 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9600 |
| Liberty Broadband Corp., Class C<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;312 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28348 |
| Liberty Global PLC, Class A (United Kingdom)<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;374 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7510 |
| Liberty Global PLC, Class C (United Kingdom)<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;643 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13297 |
| Liberty Media Corp.-Liberty Formula One, Class C<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;621 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;37844 |
| News Corp., Class A<br>| 1465 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28055 |
| News Corp., Class B<br>| &nbsp;&nbsp;&nbsp;744 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14471 |
| Paramount Global, Class B<sup>(c)</sup><br>| 1988 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;39919 |
| Playtika Holding Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;518 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4895 |
| Roku, Inc., Class A<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;162 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9618 |
| Take-Two Interactive Software, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;573 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60560 |
| Trade Desk, Inc. (The), Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;853 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;44475 |
| ZoomInfo Technologies, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;941 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26912 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;400776 |
| **Consumer Discretionary-14.64%** | **Consumer Discretionary-14.64%** | **Consumer Discretionary-14.64%** |
| Etsy, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;296 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;39099 |
| Expedia Group, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;293 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31304 |
| Hasbro, Inc.<br>| &nbsp;&nbsp;&nbsp;559 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;35116 |
| Li Auto, Inc., ADR (China)<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;656 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14432 |
| LKQ Corp.<br>| &nbsp;&nbsp;&nbsp;984 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;53461 |
| Pool Corp.<br>| &nbsp;&nbsp;&nbsp;141 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;46447 |
| Tractor Supply Co.<br>| &nbsp;&nbsp;&nbsp;385 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;87129 |
| Trip.com Group Ltd., ADR (China)<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;952 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30416 |
| Ulta Beauty, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;166 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;77165 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;414569 |
| **Consumer Staples-2.93%** | **Consumer Staples-2.93%** | **Consumer Staples-2.93%** |
| Coca-Cola Europacific Partners PLC (United Kingdom)<br>| 1562 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;82926 |
| **Health Care-17.57%** | **Health Care-17.57%** | **Health Care-17.57%** |
| 10X Genomics, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;219 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8466 |
| Alnylam Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;165 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;36397 |
| BeiGene Ltd., ADR (China)<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;83 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15904 |
| BioMarin Pharmaceutical, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;343 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34636 |
| Bio-Techne Corp.<br>| &nbsp;&nbsp;&nbsp;456 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;38755 |
| Bruker Corp.<br>| &nbsp;&nbsp;&nbsp;375 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25279 |
| DENTSPLY SIRONA, Inc.<br>| &nbsp;&nbsp;&nbsp;682 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20637 |
| Guardant Health, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;187 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9788 |
| Hologic, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;377 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28712 |
| Horizon Therapeutics PLC<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;148 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14843 |
| ICON PLC<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;312 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;67217 |
| Incyte Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;476 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;37923 |
| Insulet Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;132 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;39517 |
| Masimo Corp.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;50 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7247 |
| Novavax, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;60 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;989 |
| Repligen Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;195 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34874 |
| Royalty Pharma PLC, Class A<br>| &nbsp;&nbsp;&nbsp;613 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26954 |
| Sanofi, ADR (France)<br>| &nbsp;&nbsp;&nbsp;679 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30793 |
| Viatris, Inc.<br>| 1673 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18453 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;497384 |
| **Industrials-9.56%** | **Industrials-9.56%** | **Industrials-9.56%** |
| American Airlines Group, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;936 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13506 |
| C.H. Robinson Worldwide, Inc.<br>| &nbsp;&nbsp;&nbsp;325 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;32572 |
| CoStar Group, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;697 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;56485 |
| Expeditors International of Washington, Inc.<br>| &nbsp;&nbsp;&nbsp;523 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60699 |
| J.B. Hunt Transport Services, Inc.<br>| &nbsp;&nbsp;&nbsp;352 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;64729 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Industrials-(continued)** | **Industrials-(continued)** | **Industrials-(continued)** |
| Lyft, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;709 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$7955 |
| Sunrun, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;482 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15704 |
| United Airlines Holdings, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;428 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18905 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;270555 |
| **Information Technology-39.60%** | **Information Technology-39.60%** | **Information Technology-39.60%** |
| Affirm Holdings, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;488 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6793 |
| Akamai Technologies, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;428 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;40600 |
| Bentley Systems, Inc., Class B<br>| &nbsp;&nbsp;&nbsp;&nbsp;867 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34342 |
| CDW Corp.<br>| &nbsp;&nbsp;&nbsp;&nbsp;551 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;103941 |
| Check Point Software Technologies Ltd. (Israel)<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;280 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;37192 |
| Cognex Corp.<br>| &nbsp;&nbsp;&nbsp;&nbsp;630 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31361 |
| Coupa Software, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;207 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13091 |
| Entegris, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;339 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26201 |
| F5, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;163 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25201 |
| First Solar, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;302 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52104 |
| Gen Digital, Inc.<br>| &nbsp;&nbsp;2132 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;48951 |
| Jack Henry & Associates, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;236 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;44687 |
| Logitech International S.A., Class R (Switzerland)<br>| &nbsp;&nbsp;&nbsp;&nbsp;601 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;36385 |
| Manhattan Associates, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;167 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21032 |
| Monday.com Ltd.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;125 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13438 |
| MongoDB, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;168 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25652 |
| Monolithic Power Systems, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;118 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;45071 |
| NetApp, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;703 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;47530 |
| ON Semiconductor Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;772 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58054 |
| Open Text Corp. (Canada)<br>| &nbsp;&nbsp;&nbsp;&nbsp;818 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24033 |
| Paylocity Holding Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;135 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29407 |
| PTC, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;324 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;41216 |
| Qorvo, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;149 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14788 |
| Seagate Technology Holdings PLC<sup>(c)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;735 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;38933 |
| SolarEdge Technologies, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;113 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;33771 |
| SS&C Technologies Holdings, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;599 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;32202 |
| Teradyne, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;500 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;46725 |
| Trimble, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;884 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52819 |
| Western Digital Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;1202 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;44174 |
| Zebra Technologies Corp., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;190 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;51353 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;1121047 |
| **Materials-0.69%** | **Materials-0.69%** | **Materials-0.69%** |
| Steel Dynamics, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;188 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19539 |
| **Real Estate-0.81%** | **Real Estate-0.81%** | **Real Estate-0.81%** |
| Opendoor Technologies, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;2401 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4442 |
| Zillow Group, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;121 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4525 |
| Zillow Group, Inc., Class C<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;370 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14053 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23020 |
| TOTAL INVESTMENTS IN SECURITIES<br>(excluding investments purchased with cash collateral from securities on loan)-99.96%<br>(Cost $3,439,611) | TOTAL INVESTMENTS IN SECURITIES<br>(excluding investments purchased with cash collateral from securities on loan)-99.96%<br>(Cost $3,439,611) | &nbsp;&nbsp;2829816 |
| **Investments Purchased with Cash Collateral from Securities on Loan** | **Investments Purchased with Cash Collateral from Securities on Loan** | **Investments Purchased with Cash Collateral from Securities on Loan** |
| **Money Market Funds-6.65%** | **Money Market Funds-6.65%** | **Money Market Funds-6.65%** |
| Invesco Private Government Fund, 3.83%<sup>(d)(e)(f)</sup><br>| 52697 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52697 |

---

See accompanying notes which are an integral part of this schedule.

------

### Invesco ESG NASDAQ Next Gen 100 ETF (QQJG)—(continued)<br>
November 30, 2022

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Money Market Funds-(continued)** | **Money Market Funds-(continued)** | **Money Market Funds-(continued)** |
| Invesco Private Prime Fund, 4.15%<sup>(d)(e)(f)</sup><br>| 135446 | &nbsp;&nbsp;&nbsp;$135473 |
| &nbsp;&nbsp;&nbsp;Total Investments Purchased with Cash Collateral from Securities on Loan<br>(Cost $188,157) | &nbsp;&nbsp;&nbsp;Total Investments Purchased with Cash Collateral from Securities on Loan<br>(Cost $188,157) | &nbsp;&nbsp;&nbsp;&nbsp;188170 |
| TOTAL INVESTMENTS IN SECURITIES-106.61%<br>(Cost $3,627,768) | TOTAL INVESTMENTS IN SECURITIES-106.61%<br>(Cost $3,627,768) | &nbsp;&nbsp;3017986 |
| OTHER ASSETS LESS LIABILITIES-(6.61)% | OTHER ASSETS LESS LIABILITIES-(6.61)% | &nbsp;&nbsp;&nbsp;&nbsp;(187072) |
| NET ASSETS-100.00% | NET ASSETS-100.00% | $2830914 |

---

Investment Abbreviations: <br> ADR -American Depositary Receipt

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is the exclusive property and a service mark of MSCI Inc. and Standard & Poor's. |
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at November 30, 2022. |
| <sup>(d)</sup> | Affiliated issuer. The issuer and/or the Fund is a wholly-owned subsidiary of Invesco Ltd., or is affiliated by having an investment adviser that is under common control of Invesco Ltd. The table below shows the Fund's transactions in, and earnings from, its investments in affiliates for the three months ended November 30, 2022. |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;&nbsp;**Value<br> August 31, 2022** | &nbsp;&nbsp;&nbsp;**Purchases<br> at Cost** | &nbsp;&nbsp;&nbsp;**Proceeds<br> from Sales** | &nbsp;&nbsp;&nbsp;**Change in<br> Unrealized<br> Appreciation** | &nbsp;&nbsp;&nbsp;**Realized<br> Gain** | &nbsp;&nbsp;&nbsp;**Value<br> November 30, 2022** | &nbsp;&nbsp;&nbsp;**Dividend<br> Income** |
| &nbsp;&nbsp;**Investments in Affiliated Money Market Funds:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Invesco Government & Agency Portfolio, Institutional Class | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$279 | &nbsp;&nbsp;&nbsp;&nbsp;$6358 | &nbsp;&nbsp;&nbsp;&nbsp;$(6637) | &nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$9 |
| &nbsp;&nbsp;**Investments Purchased with Cash Collateral from Securities on Loan:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Invesco Private Government Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;38307 | &nbsp;&nbsp;&nbsp;&nbsp;293474 | &nbsp;&nbsp;&nbsp;&nbsp;(279084) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52697 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;403\* |
| &nbsp;&nbsp;Invesco Private Prime Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;98504 | &nbsp;&nbsp;&nbsp;&nbsp;660533 | &nbsp;&nbsp;&nbsp;&nbsp;(623588) | &nbsp;&nbsp;&nbsp;&nbsp;10 | &nbsp;&nbsp;&nbsp;&nbsp;14 | &nbsp;&nbsp;&nbsp;&nbsp;135473 | &nbsp;&nbsp;&nbsp;&nbsp;1,126\* |
| &nbsp;&nbsp;Total | &nbsp;&nbsp;&nbsp;$137090 | &nbsp;&nbsp;&nbsp;$960365 | &nbsp;&nbsp;&nbsp;$(909309) | &nbsp;&nbsp;&nbsp;$10 | &nbsp;&nbsp;&nbsp;$14 | &nbsp;&nbsp;&nbsp;$188170 | &nbsp;&nbsp;&nbsp;$1538 |

---

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of November 30, 2022. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup><br>

### Invesco NASDAQ 100 ETF (QQQM)
November 30, 2022

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Common Stocks & Other Equity Interests-99.98%** | **Common Stocks & Other Equity Interests-99.98%** | **Common Stocks & Other Equity Interests-99.98%** |
| **Communication Services-15.36%** | **Communication Services-15.36%** | **Communication Services-15.36%** |
| Activision Blizzard, Inc.<br>| &nbsp;&nbsp;&nbsp;425459 | &nbsp;&nbsp;$31462693 |
| Alphabet, Inc., Class A<sup>(b)</sup><br>| 1965633 | &nbsp;&nbsp;&nbsp;&nbsp;198509277 |
| Alphabet, Inc., Class C<sup>(b)</sup><br>| 2020382 | &nbsp;&nbsp;&nbsp;&nbsp;204967754 |
| Baidu, Inc., ADR (China)<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;99012 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10752703 |
| Charter Communications, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;87418 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34205789 |
| Comcast Corp., Class A<br>| 2395141 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;87757966 |
| Electronic Arts, Inc.<br>| &nbsp;&nbsp;&nbsp;151198 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19773675 |
| Match Group, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;153924 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7782397 |
| Meta Platforms, Inc., Class A<sup>(b)</sup><br>| 1119505 | &nbsp;&nbsp;&nbsp;&nbsp;132213541 |
| NetEase, Inc., ADR (China)<br>| &nbsp;&nbsp;&nbsp;&nbsp;88350 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6283452 |
| Netflix, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;241827 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;73885403 |
| Sirius XM Holdings, Inc.<sup>(c)</sup><br>| 2118039 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13746073 |
| T-Mobile US, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;682076 | &nbsp;&nbsp;&nbsp;&nbsp;103307231 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;924647954 |
| **Consumer Discretionary-14.31%** | **Consumer Discretionary-14.31%** | **Consumer Discretionary-14.31%** |
| Airbnb, Inc., Class A<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;217141 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22178782 |
| Amazon.com, Inc.<sup>(b)</sup><br>| 3339689 | &nbsp;&nbsp;&nbsp;&nbsp;322413576 |
| Booking Holdings, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;21568 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;44849577 |
| Dollar Tree, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;121761 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18299461 |
| eBay, Inc.<br>| &nbsp;&nbsp;&nbsp;298801 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13577517 |
| JD.com, Inc., ADR (China)<br>| &nbsp;&nbsp;&nbsp;274460 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15693623 |
| Lucid Group, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;912550 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9253257 |
| lululemon athletica, inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;66505 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25292516 |
| Marriott International, Inc., Class A<br>| &nbsp;&nbsp;&nbsp;176486 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29181960 |
| MercadoLibre, Inc. (Brazil)<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;27337 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25450337 |
| O'Reilly Automotive, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;34446 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29779945 |
| Pinduoduo, Inc., ADR (China)<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;254578 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20885579 |
| Ross Stores, Inc.<br>| &nbsp;&nbsp;&nbsp;190307 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22393425 |
| Starbucks Corp.<br>| &nbsp;&nbsp;&nbsp;624044 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;63777297 |
| Tesla, Inc.<sup>(b)</sup><br>| 1018867 | &nbsp;&nbsp;&nbsp;&nbsp;198373405 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;861400257 |
| **Consumer Staples-7.05%** | **Consumer Staples-7.05%** | **Consumer Staples-7.05%** |
| Costco Wholesale Corp.<br>| &nbsp;&nbsp;&nbsp;240896 | &nbsp;&nbsp;&nbsp;&nbsp;129903168 |
| Keurig Dr Pepper, Inc.<br>| &nbsp;&nbsp;&nbsp;770167 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29782358 |
| Kraft Heinz Co. (The)<br>| &nbsp;&nbsp;&nbsp;666530 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26227956 |
| Mondelez International, Inc., Class A<br>| &nbsp;&nbsp;&nbsp;745393 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;50396021 |
| Monster Beverage Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;286527 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29472167 |
| PepsiCo, Inc.<br>| &nbsp;&nbsp;&nbsp;750471 | &nbsp;&nbsp;&nbsp;&nbsp;139219875 |
| Walgreens Boots Alliance, Inc.<br>| &nbsp;&nbsp;&nbsp;470036 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19506494 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;424508039 |
| **Health Care-7.48%** | **Health Care-7.48%** | **Health Care-7.48%** |
| Align Technology, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;42522 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8362377 |
| Amgen, Inc.<br>| &nbsp;&nbsp;&nbsp;290913 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;83317483 |
| AstraZeneca PLC, ADR (United Kingdom)<br>| &nbsp;&nbsp;&nbsp;321936 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21881990 |
| Biogen, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;78940 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24090120 |
| DexCom, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;213536 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24829966 |
| Gilead Sciences, Inc.<br>| &nbsp;&nbsp;&nbsp;681716 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;59875116 |
| IDEXX Laboratories, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;45274 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19280838 |
| Illumina, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;85540 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18654563 |
| Intuitive Surgical, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;194233 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52518661 |
| Moderna, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;212796 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;37432944 |
| Regeneron Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;58325 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;43842903 |
| Seagen, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;100302 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12175660 |
| Vertex Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;139487 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;44133687 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;450396308 |
| **Industrials-3.84%** | **Industrials-3.84%** | **Industrials-3.84%** |
| Cintas Corp.<br>| &nbsp;&nbsp;&nbsp;&nbsp;55490 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25624172 |
| Copart, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;258547 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17208888 |
| CSX Corp.<br>| 1164548 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;38069074 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Industrials-(continued)** | **Industrials-(continued)** | **Industrials-(continued)** |
| Fastenal Co.<br>| &nbsp;&nbsp;&nbsp;312587 | &nbsp;&nbsp;&nbsp;&nbsp;$16101357 |
| Honeywell International, Inc.<br>| &nbsp;&nbsp;&nbsp;366373 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;80437192 |
| Old Dominion Freight Line, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;60776 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18391425 |
| PACCAR, Inc.<br>| &nbsp;&nbsp;&nbsp;189126 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20030335 |
| Verisk Analytics, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;85359 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15681302 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;231543745 |
| **Information Technology-50.49%** | **Information Technology-50.49%** | **Information Technology-50.49%** |
| Adobe, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;254536 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;87797102 |
| Advanced Micro Devices, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;878003 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;68159373 |
| Analog Devices, Inc.<br>| &nbsp;&nbsp;&nbsp;279736 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;48089416 |
| ANSYS, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;47314 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12031950 |
| Apple, Inc.<br>| 5268377 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;779877847 |
| Applied Materials, Inc.<br>| &nbsp;&nbsp;&nbsp;467925 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;51284580 |
| ASML Holding N.V., New York Shares (Netherlands)<br>| &nbsp;&nbsp;&nbsp;&nbsp;46793 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28455759 |
| Atlassian Corp., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;78821 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10368903 |
| Autodesk, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;117441 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23717210 |
| Automatic Data Processing, Inc.<br>| &nbsp;&nbsp;&nbsp;225968 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;59687188 |
| Broadcom, Inc.<br>| &nbsp;&nbsp;&nbsp;220248 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;121363255 |
| Cadence Design Systems, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;148965 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25627939 |
| Cisco Systems, Inc.<br>| 2252164 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;111977594 |
| Cognizant Technology Solutions Corp., Class A<br>| &nbsp;&nbsp;&nbsp;281577 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17516905 |
| Crowdstrike Holdings, Inc., Class A<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;116809 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13742579 |
| Datadog, Inc., Class A<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;158195 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11988017 |
| DocuSign, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;108763 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5119474 |
| Enphase Energy, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;73692 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23624918 |
| Fiserv, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;347882 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;36304966 |
| Fortinet, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;428866 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22798517 |
| Intel Corp.<br>| 2233215 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;67152775 |
| Intuit, Inc.<br>| &nbsp;&nbsp;&nbsp;153438 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;62539794 |
| KLA Corp.<br>| &nbsp;&nbsp;&nbsp;&nbsp;77086 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30306361 |
| Lam Research Corp.<br>| &nbsp;&nbsp;&nbsp;&nbsp;74511 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;35197506 |
| Marvell Technology, Inc.<br>| &nbsp;&nbsp;&nbsp;463719 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21572208 |
| Microchip Technology, Inc.<br>| &nbsp;&nbsp;&nbsp;300467 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23793982 |
| Micron Technology, Inc.<br>| &nbsp;&nbsp;&nbsp;599960 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34587694 |
| Microsoft Corp.<br>| 2444871 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;623784387 |
| NVIDIA Corp.<br>| 1148750 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;194402962 |
| NXP Semiconductors N.V. (China)<br>| &nbsp;&nbsp;&nbsp;142854 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25119447 |
| Palo Alto Networks, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;162605 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27626590 |
| Paychex, Inc.<br>| &nbsp;&nbsp;&nbsp;195727 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24276020 |
| PayPal Holdings, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;628981 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;49318400 |
| QUALCOMM, Inc.<br>| &nbsp;&nbsp;&nbsp;610745 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;77253135 |
| Skyworks Solutions, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;87222 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8340168 |
| Splunk, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;88512 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6875612 |
| Synopsys, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;83194 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28247691 |
| Texas Instruments, Inc.<br>| &nbsp;&nbsp;&nbsp;496983 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;89685552 |
| VeriSign, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;58375 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11663909 |
| Workday, Inc., Class A<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;109328 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18356171 |
| Zoom Video Communications, Inc., Class A<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;136471 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10294008 |
| Zscaler, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;77118 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10291397 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;3040219261 |
| **Utilities-1.45%** | **Utilities-1.45%** | **Utilities-1.45%** |
| American Electric Power Co., Inc.<br>| &nbsp;&nbsp;&nbsp;279411 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27046985 |
| Constellation Energy Corp.<br>| &nbsp;&nbsp;&nbsp;177680 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17078602 |

---

See accompanying notes which are an integral part of this schedule.

------

### Invesco NASDAQ 100 ETF (QQQM)—(continued)<br>
November 30, 2022

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Utilities-(continued)** | **Utilities-(continued)** | **Utilities-(continued)** |
| Exelon Corp.<br>| &nbsp;&nbsp;&nbsp;&nbsp;540296 | &nbsp;&nbsp;&nbsp;&nbsp;$22352045 |
| Xcel Energy, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;297530 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20892556 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;87370188 |
| TOTAL INVESTMENTS IN SECURITIES<br>(excluding investments purchased with cash collateral from securities on loan)-99.98%<br>(Cost $7,083,606,840) | TOTAL INVESTMENTS IN SECURITIES<br>(excluding investments purchased with cash collateral from securities on loan)-99.98%<br>(Cost $7,083,606,840) | &nbsp;&nbsp;6020085752 |
| **Investments Purchased with Cash Collateral from Securities on Loan** | **Investments Purchased with Cash Collateral from Securities on Loan** | **Investments Purchased with Cash Collateral from Securities on Loan** |
| **Money Market Funds-1.18%** | **Money Market Funds-1.18%** | **Money Market Funds-1.18%** |
| Invesco Private Government Fund, 3.83%<sup>(d)(e)(f)</sup><br>| 20019750 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20019750 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Money Market Funds-(continued)** | **Money Market Funds-(continued)** | **Money Market Funds-(continued)** |
| Invesco Private Prime Fund, 4.15%<sup>(d)(e)(f)</sup><br>| 51453261 | &nbsp;&nbsp;&nbsp;&nbsp;$51463550 |
| &nbsp;&nbsp;&nbsp;Total Investments Purchased with Cash Collateral from Securities on Loan<br>(Cost $71,478,321) | &nbsp;&nbsp;&nbsp;Total Investments Purchased with Cash Collateral from Securities on Loan<br>(Cost $71,478,321) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;71483300 |
| TOTAL INVESTMENTS IN SECURITIES-101.16%<br>(Cost $7,155,085,161) | TOTAL INVESTMENTS IN SECURITIES-101.16%<br>(Cost $7,155,085,161) | &nbsp;&nbsp;6091569052 |
| OTHER ASSETS LESS LIABILITIES-(1.16)% | OTHER ASSETS LESS LIABILITIES-(1.16)% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(70139845) |
| NET ASSETS-100.00% | NET ASSETS-100.00% | $6021429207 |

---

Investment Abbreviations: <br> ADR -American Depositary Receipt

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is the exclusive property and a service mark of MSCI Inc. and Standard & Poor's. |
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at November 30, 2022. |
| <sup>(d)</sup> | Affiliated issuer. The issuer and/or the Fund is a wholly-owned subsidiary of Invesco Ltd., or is affiliated by having an investment adviser that is under common control of Invesco Ltd. The table below shows the Fund's transactions in, and earnings from, its investments in affiliates for the three months ended November 30, 2022. |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;&nbsp;**Value<br> August 31, 2022** | &nbsp;&nbsp;&nbsp;**Purchases<br> at Cost** | &nbsp;&nbsp;&nbsp;**Proceeds<br> from Sales** | &nbsp;&nbsp;&nbsp;**Change in<br> Unrealized<br> Appreciation** | &nbsp;&nbsp;&nbsp;**Realized<br> Gain** | &nbsp;&nbsp;&nbsp;**Value<br> November 30, 2022** | &nbsp;&nbsp;&nbsp;**Dividend<br> Income** |
| &nbsp;&nbsp;**Investments in Affiliated Money Market Funds:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Invesco Government & Agency Portfolio, Institutional Class | &nbsp;&nbsp;&nbsp;$3899314 | &nbsp;&nbsp;&nbsp;$17577531 | &nbsp;&nbsp;&nbsp;$(21476845) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;&nbsp;$19007 |
| &nbsp;&nbsp;**Investments Purchased with Cash Collateral from Securities on Loan:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Invesco Private Government Fund | &nbsp;&nbsp;&nbsp;&nbsp;20827857 | &nbsp;&nbsp;&nbsp;&nbsp;152076366 | &nbsp;&nbsp;&nbsp;&nbsp;(152884473) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;20019750 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;269,433\* |
| &nbsp;&nbsp;Invesco Private Prime Fund | &nbsp;&nbsp;&nbsp;&nbsp;53557349 | &nbsp;&nbsp;&nbsp;&nbsp;310460070 | &nbsp;&nbsp;&nbsp;&nbsp;(312560297) | &nbsp;&nbsp;&nbsp;&nbsp;1841 | &nbsp;&nbsp;&nbsp;&nbsp;4587 | &nbsp;&nbsp;&nbsp;&nbsp;51463550 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;724,055\* |
| &nbsp;&nbsp;Total | &nbsp;&nbsp;&nbsp;$78284520 | &nbsp;&nbsp;&nbsp;$480113967 | &nbsp;&nbsp;&nbsp;$(486921615) | &nbsp;&nbsp;&nbsp;$1841 | &nbsp;&nbsp;&nbsp;$4587 | &nbsp;&nbsp;&nbsp;$71483300 | &nbsp;&nbsp;&nbsp;$1012495 |

---

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of November 30, 2022. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup><br>

### Invesco NASDAQ Future Gen 200 ETF (QQQS)
November 30, 2022

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Common Stocks & Other Equity Interests-99.99%** | **Common Stocks & Other Equity Interests-99.99%** | **Common Stocks & Other Equity Interests-99.99%** |
| **Communication Services-1.10%** | **Communication Services-1.10%** | **Communication Services-1.10%** |
| EchoStar Corp., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;1346 | &nbsp;&nbsp;$23420 |
| TrueCar, Inc.<sup>(b)</sup><br>| 11493 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28618 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52038 |
| **Consumer Discretionary-6.05%** | **Consumer Discretionary-6.05%** | **Consumer Discretionary-6.05%** |
| BRP, Inc. (Canada)<br>| &nbsp;&nbsp;&nbsp;&nbsp;362 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27088 |
| Garrett Motion, Inc. (Switzerland)<sup>(b)</sup><br>| &nbsp;&nbsp;3642 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25785 |
| Gentex Corp.<br>| &nbsp;&nbsp;&nbsp;&nbsp;907 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26212 |
| Gentherm, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;419 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29996 |
| Goodyear Tire & Rubber Co. (The)<sup>(b)</sup><br>| &nbsp;&nbsp;1767 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19826 |
| GoPro, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;4070 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22304 |
| iRobot Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;422 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21982 |
| Sleep Number Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;598 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17492 |
| Sonos, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1650 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28925 |
| Universal Electronics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1116 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24407 |
| VOXX International Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;2604 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28618 |
| Vuzix Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;3297 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13748 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;286383 |
| **Consumer Staples-0.46%** | **Consumer Staples-0.46%** | **Consumer Staples-0.46%** |
| 22nd Century Group, Inc.<sup>(b)</sup><br>| 18481 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21808 |
| **Energy-1.42%** | **Energy-1.42%** | **Energy-1.42%** |
| Baker Hughes Co., Class A<br>| &nbsp;&nbsp;&nbsp;&nbsp;984 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28556 |
| Weatherford International PLC<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;889 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;38582 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;67138 |
| **Health Care-53.90%** | **Health Care-53.90%** | **Health Care-53.90%** |
| Accuray, Inc.<sup>(b)</sup><br>| 10554 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21636 |
| Aclaris Therapeutics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1561 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23758 |
| Adaptimmune Therapeutics PLC, ADR<sup>(b)</sup><br>| 12660 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27472 |
| Agenus, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;9196 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24829 |
| Agios Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;984 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29658 |
| Albireo Pharma, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1431 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31596 |
| Aldeyra Therapeutics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;3517 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19695 |
| Alphatec Holdings, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;3302 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;33879 |
| Altimmune, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1123 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11174 |
| Amarin Corp. PLC, ADR (Ireland)<sup>(b)</sup><br>| 21274 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24465 |
| Amicus Therapeutics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;2210 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26741 |
| AngioDynamics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1119 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14491 |
| Anika Therapeutics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1108 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34946 |
| Apyx Medical Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;4325 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7612 |
| Arbutus Biopharma Corp.<sup>(b)</sup><br>| 11186 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26287 |
| AtriCure, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;549 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25012 |
| Avadel Pharmaceuticals PLC, ADR<sup>(b)</sup><br>| &nbsp;&nbsp;3740 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34296 |
| Azenta, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;471 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28359 |
| Bicycle Therapeutics PLC, ADR (United Kingdom)<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;937 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27136 |
| Bionano Genomics, Inc.<sup>(b)</sup><br>| 10121 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20343 |
| Bluebird Bio, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;4248 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;33092 |
| Cara Therapeutics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;2402 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28344 |
| Cardiovascular Systems, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1900 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26619 |
| Chimerix, Inc.<sup>(b)</sup><br>| 11273 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24462 |
| ChromaDex Corp.<sup>(b)</sup><br>| 17241 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29655 |
| ClearPoint Neuro, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1924 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18143 |
| Clovis Oncology, Inc.<sup>(b)</sup><br>| 22169 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7316 |
| Codexis, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;3535 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19336 |
| Coherus Biosciences, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;2217 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15209 |
| Compugen Ltd. (Israel)<sup>(b)</sup><br>| 21167 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25400 |
| Concert Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;3762 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18133 |
| CTI BioPharma Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;3946 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23755 |
| Cymabay Therapeutics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;7017 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23717 |
| CytomX Therapeutics, Inc.<sup>(b)</sup><br>| 16738 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29124 |
| Dare Bioscience, Inc.<sup>(b)</sup><br>| 23256 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20700 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Health Care-(continued)** | **Health Care-(continued)** | **Health Care-(continued)** |
| Eagle Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;761 | &nbsp;&nbsp;$27640 |
| Enanta Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;408 | &nbsp;&nbsp;&nbsp;&nbsp;17866 |
| FibroGen, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;2016 | &nbsp;&nbsp;&nbsp;&nbsp;28970 |
| G1 Therapeutics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1704 | &nbsp;&nbsp;&nbsp;&nbsp;10156 |
| Geron Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;9383 | &nbsp;&nbsp;&nbsp;&nbsp;21769 |
| Heron Therapeutics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;6069 | &nbsp;&nbsp;&nbsp;&nbsp;16447 |
| ICU Medical, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;157 | &nbsp;&nbsp;&nbsp;&nbsp;24999 |
| IGM Biosciences, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1277 | &nbsp;&nbsp;&nbsp;&nbsp;28107 |
| ImmunoGen, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;4269 | &nbsp;&nbsp;&nbsp;&nbsp;22156 |
| Innoviva, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1886 | &nbsp;&nbsp;&nbsp;&nbsp;24763 |
| Inovio Pharmaceuticals, Inc.<sup>(b)</sup><br>| 10828 | &nbsp;&nbsp;&nbsp;&nbsp;22089 |
| Integra LifeSciences Holdings Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;521 | &nbsp;&nbsp;&nbsp;&nbsp;28624 |
| Intercept Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1427 | &nbsp;&nbsp;&nbsp;&nbsp;21277 |
| Ionis Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;582 | &nbsp;&nbsp;&nbsp;&nbsp;23740 |
| Ironwood Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;2332 | &nbsp;&nbsp;&nbsp;&nbsp;28241 |
| KalVista Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1550 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8354 |
| Karyopharm Therapeutics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;4910 | &nbsp;&nbsp;&nbsp;&nbsp;25974 |
| Lexicon Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;8999 | &nbsp;&nbsp;&nbsp;&nbsp;19258 |
| Ligand Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;272 | &nbsp;&nbsp;&nbsp;&nbsp;19829 |
| Liquidia Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;4291 | &nbsp;&nbsp;&nbsp;&nbsp;21541 |
| LivaNova PLC<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;441 | &nbsp;&nbsp;&nbsp;&nbsp;24418 |
| MacroGenics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;6254 | &nbsp;&nbsp;&nbsp;&nbsp;40213 |
| MannKind Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;6870 | &nbsp;&nbsp;&nbsp;&nbsp;32152 |
| Merit Medical Systems, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;421 | &nbsp;&nbsp;&nbsp;&nbsp;30312 |
| Mersana Therapeutics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;3302 | &nbsp;&nbsp;&nbsp;&nbsp;21991 |
| Merus N.V. (Netherlands)<sup>(b)</sup><br>| &nbsp;&nbsp;1064 | &nbsp;&nbsp;&nbsp;&nbsp;16332 |
| MiMedx Group, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;7023 | &nbsp;&nbsp;&nbsp;&nbsp;22825 |
| NanoString Technologies, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1830 | &nbsp;&nbsp;&nbsp;&nbsp;12792 |
| Nektar Therapeutics<sup>(b)</sup><br>| &nbsp;&nbsp;6293 | &nbsp;&nbsp;&nbsp;&nbsp;17620 |
| NGM Biopharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1803 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9971 |
| NuVasive, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;582 | &nbsp;&nbsp;&nbsp;&nbsp;22605 |
| Omeros Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;6150 | &nbsp;&nbsp;&nbsp;&nbsp;13161 |
| OmniAb, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1309 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4634 |
| OmniAb, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;83 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- |
| OmniAb, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;83 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- |
| OPKO Health, Inc.<sup>(b)</sup><br>| 11367 | &nbsp;&nbsp;&nbsp;&nbsp;17050 |
| Oramed Pharmaceuticals, Inc. (Israel)<sup>(b)</sup><br>| &nbsp;&nbsp;2895 | &nbsp;&nbsp;&nbsp;&nbsp;24463 |
| OraSure Technologies, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;6124 | &nbsp;&nbsp;&nbsp;&nbsp;30865 |
| Orthofix Medical, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1245 | &nbsp;&nbsp;&nbsp;&nbsp;22398 |
| Pacific Biosciences of California, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;4269 | &nbsp;&nbsp;&nbsp;&nbsp;45892 |
| Paratek Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;9875 | &nbsp;&nbsp;&nbsp;&nbsp;21922 |
| PDS Biotechnology Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;5967 | &nbsp;&nbsp;&nbsp;&nbsp;53882 |
| Personalis, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;7485 | &nbsp;&nbsp;&nbsp;&nbsp;19012 |
| Pieris Pharmaceuticals, Inc.<sup>(b)</sup><br>| 16965 | &nbsp;&nbsp;&nbsp;&nbsp;16549 |
| Precision BioSciences, Inc.<sup>(b)</sup><br>| 15390 | &nbsp;&nbsp;&nbsp;&nbsp;21084 |
| Prothena Corp. PLC (Ireland)<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;906 | &nbsp;&nbsp;&nbsp;&nbsp;56634 |
| PTC Therapeutics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;495 | &nbsp;&nbsp;&nbsp;&nbsp;20538 |
| Reata Pharmaceuticals, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;1048 | &nbsp;&nbsp;&nbsp;&nbsp;41480 |
| Revance Therapeutics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1260 | &nbsp;&nbsp;&nbsp;&nbsp;27355 |
| Rigel Pharmaceuticals, Inc.<sup>(b)</sup><br>| 17802 | &nbsp;&nbsp;&nbsp;&nbsp;11956 |
| Sangamo Therapeutics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;4592 | &nbsp;&nbsp;&nbsp;&nbsp;16807 |
| Selecta Biosciences, Inc.<sup>(b)</sup><br>| 13182 | &nbsp;&nbsp;&nbsp;&nbsp;17268 |
| Seres Therapeutics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;4876 | &nbsp;&nbsp;&nbsp;&nbsp;31694 |
| Sesen Bio, Inc.<sup>(b)</sup><br>| 35907 | &nbsp;&nbsp;&nbsp;&nbsp;19885 |
| SI-BONE, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1500 | &nbsp;&nbsp;&nbsp;&nbsp;18420 |
| SIGA Technologies, Inc.<br>| &nbsp;&nbsp;1643 | &nbsp;&nbsp;&nbsp;&nbsp;15083 |
| Silk Road Medical, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;625 | &nbsp;&nbsp;&nbsp;&nbsp;33281 |
| Sorrento Therapeutics, Inc.<sup>(b)</sup><br>| 12073 | &nbsp;&nbsp;&nbsp;&nbsp;15695 |
| Spectrum Pharmaceuticals, Inc.<sup>(b)</sup><br>| 22502 | &nbsp;&nbsp;&nbsp;&nbsp;10364 |
| Standard BioTools, Inc.<sup>(b)</sup><br>| 17813 | &nbsp;&nbsp;&nbsp;&nbsp;24760 |
| Supernus Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;725 | &nbsp;&nbsp;&nbsp;&nbsp;26622 |
| Surface Oncology, Inc.<sup>(b)</sup><br>| 18223 | &nbsp;&nbsp;&nbsp;&nbsp;16765 |

---

See accompanying notes which are an integral part of this schedule.

------

### Invesco NASDAQ Future Gen 200 ETF (QQQS)—(continued)<br>
November 30, 2022

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Health Care-(continued)** | **Health Care-(continued)** | **Health Care-(continued)** |
| SurModics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;735 | &nbsp;&nbsp;&nbsp;&nbsp;$26556 |
| Sutro Biopharma, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;4386 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;32851 |
| Tactile Systems Technology, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;3044 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26057 |
| Theravance Biopharma, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;2754 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29633 |
| uniQure N.V. (Netherlands)<sup>(b)</sup><br>| &nbsp;&nbsp;1272 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;33657 |
| UroGen Pharma Ltd.<sup>(b)</sup><br>| &nbsp;&nbsp;3369 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28872 |
| Vanda Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;2373 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25889 |
| Varex Imaging Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;1175 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24957 |
| Verastem, Inc.<sup>(b)</sup><br>| 21891 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10070 |
| ViewRay, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;7327 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;35316 |
| Voyager Therapeutics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;4162 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24722 |
| Xencor, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;951 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28264 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;2551784 |
| **Industrials-3.44%** | **Industrials-3.44%** | **Industrials-3.44%** |
| AeroVironment, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;278 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25573 |
| American Superconductor Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;4640 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17446 |
| Astronics Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;2689 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22588 |
| Interface, Inc.<br>| &nbsp;&nbsp;2247 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24335 |
| Nordson Corp.<br>| &nbsp;&nbsp;&nbsp;&nbsp;108 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25541 |
| SunPower Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;1047 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25390 |
| Westport Fuel Systems, Inc. (Canada)<sup>(b)</sup><br>| 22757 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21844 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;162717 |
| **Information Technology-32.65%** | **Information Technology-32.65%** | **Information Technology-32.65%** |
| ADTRAN Holdings, Inc.<br>| &nbsp;&nbsp;1082 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21932 |
| Aehr Test Systems<sup>(b)</sup><br>| &nbsp;&nbsp;1721 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;44866 |
| Allot Ltd. (Israel)<sup>(b)</sup><br>| &nbsp;&nbsp;5461 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20260 |
| Alpha & Omega Semiconductor Ltd.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;642 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22521 |
| Amkor Technology, Inc.<br>| &nbsp;&nbsp;1244 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34857 |
| Atomera, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1916 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16343 |
| Aviat Networks, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;802 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25231 |
| Axcelis Technologies, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;371 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29628 |
| Bel Fuse, Inc., Class B<br>| &nbsp;&nbsp;&nbsp;&nbsp;882 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30376 |
| Brightcove, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;3740 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20682 |
| CalAmp Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;4015 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14494 |
| Cirrus Logic, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;323 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24131 |
| CommScope Holding Co., Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;2194 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19483 |
| CommVault Systems, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;457 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30162 |
| Comtech Telecommunications Corp.<br>| &nbsp;&nbsp;2195 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25616 |
| Digimarc Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;1406 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31326 |
| Dropbox, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;1159 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27306 |
| Edgio, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;6736 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9700 |
| EMCORE Corp.<sup>(b)</sup><br>| 10422 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14799 |
| Everspin Technologies, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;3398 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22971 |
| Extreme Networks, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1749 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;36677 |
| FARO Technologies, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;748 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22380 |
| Flex Ltd.<sup>(b)</sup><br>| &nbsp;&nbsp;1394 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30640 |
| Gilat Satellite Networks Ltd. (Israel)<sup>(b)</sup><br>| &nbsp;&nbsp;3774 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23323 |
| Himax Technologies, Inc., ADR (Taiwan)<br>| &nbsp;&nbsp;4024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29657 |
| Immersion Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;4160 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30202 |
| Impinj, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;277 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;35331 |
| Infinera Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;4575 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30881 |
| Inseego Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;9183 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11662 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Information Technology-(continued)** | **Information Technology-(continued)** | **Information Technology-(continued)** |
| InterDigital, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;494 | &nbsp;&nbsp;&nbsp;&nbsp;$24784 |
| IPG Photonics Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;276 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25124 |
| Itron, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;522 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27760 |
| Kimball Electronics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1166 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26923 |
| Kopin Corp.<sup>(b)</sup><br>| 18092 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29309 |
| Lantronix, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;4092 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20951 |
| Lattice Semiconductor Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;464 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;33793 |
| Littelfuse, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;104 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25636 |
| LivePerson, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;2137 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25088 |
| Lumentum Holdings, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;302 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16592 |
| Luna Innovations, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;4366 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29514 |
| Materialise N.V., ADR (Belgium)<sup>(b)</sup><br>| &nbsp;&nbsp;2121 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20468 |
| MaxLinear, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;691 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25291 |
| MicroVision, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;5123 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15523 |
| Mitek Systems, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;2429 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24849 |
| MKS Instruments, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;250 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20965 |
| NETGEAR, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1067 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21052 |
| nLight, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1984 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21546 |
| OSI Systems, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;301 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26633 |
| Power Integrations, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;351 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28249 |
| Quantum Corp.<sup>(b)</sup><br>| 15798 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20063 |
| Rambus, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;965 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;37037 |
| Ribbon Communications, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;7068 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17882 |
| SecureWorks Corp., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;2381 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17096 |
| Sierra Wireless, Inc. (Canada)<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;816 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23933 |
| Smith Micro Software, Inc.<sup>(b)</sup><br>| 10204 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22959 |
| Stratasys Ltd.<sup>(b)</sup><br>| &nbsp;&nbsp;1434 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20119 |
| Synaptics, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;215 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22784 |
| Turtle Beach Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;2637 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25183 |
| Universal Display Corp.<br>| &nbsp;&nbsp;&nbsp;&nbsp;224 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25227 |
| Veeco Instruments, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1172 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23299 |
| Verint Systems, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;511 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20098 |
| Viasat, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;662 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22568 |
| Viavi Solutions, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;1765 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19997 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;1545732 |
| **Materials-0.97%** | **Materials-0.97%** | **Materials-0.97%** |
| Amyris, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;8433 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14589 |
| Haynes International, Inc.<br>| &nbsp;&nbsp;&nbsp;&nbsp;626 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31275 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;45864 |
| &nbsp;&nbsp;&nbsp;Total Common Stocks & Other Equity Interests<br>(Cost $4,358,569) | &nbsp;&nbsp;&nbsp;Total Common Stocks & Other Equity Interests<br>(Cost $4,358,569) | &nbsp;&nbsp;4733464 |
| **Money Market Funds-0.02%** | **Money Market Funds-0.02%** | **Money Market Funds-0.02%** |
| Invesco Government & Agency Portfolio, Institutional Class, 3.73%<sup>(d)(e)</sup><br>(Cost $1,144)<br>| &nbsp;&nbsp;1144 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1144 |
| TOTAL INVESTMENTS IN SECURITIES-100.01%<br>(Cost $4,359,713) | TOTAL INVESTMENTS IN SECURITIES-100.01%<br>(Cost $4,359,713) | &nbsp;&nbsp;4734608 |
| OTHER ASSETS LESS LIABILITIES-(0.01)% | OTHER ASSETS LESS LIABILITIES-(0.01)% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(398) |
| NET ASSETS-100.00% | NET ASSETS-100.00% | $4734210 |

---

See accompanying notes which are an integral part of this schedule.

------

November 30, 2022

(Unaudited)

Investment Abbreviations: <br> ADR -American Depositary Receipt

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is the exclusive property and a service mark of MSCI Inc. and Standard & Poor's. |
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | Security valued using significant unobservable inputs (Level 3). See Note 1. |
| <sup>(d)</sup> | Affiliated issuer. The issuer and/or the Fund is a wholly-owned subsidiary of Invesco Ltd., or is affiliated by having an investment adviser that is under common control of Invesco Ltd. The table below shows the Fund's transactions in, and earnings from, its investments in affiliates for the period ended November 30, 2022. |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;&nbsp;**Value<br> August 31, 2022** | &nbsp;&nbsp;&nbsp;**Purchases<br> at Cost** | &nbsp;&nbsp;&nbsp;**Proceeds<br> from Sales** | &nbsp;&nbsp;&nbsp;**Change in<br> Unrealized<br> Appreciation** | &nbsp;&nbsp;&nbsp;**Realized<br> Gain** | &nbsp;&nbsp;&nbsp;**Value<br> November 30, 2022** | &nbsp;&nbsp;&nbsp;**Dividend<br> Income** |
| &nbsp;&nbsp;**Investments in Affiliated Money Market Funds:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Invesco Government & Agency Portfolio, Institutional Class | &nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$32145 | &nbsp;&nbsp;&nbsp;$(31001) | &nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$1144 | &nbsp;&nbsp;&nbsp;$9 |

---

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of November 30, 2022.

The valuation policy and a listing of other significant accounting policies are available in the most recent Statement of Additional Information.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup><br>

### Invesco NASDAQ Next Gen 100 ETF (QQQJ)
November 30, 2022

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Common Stocks & Other Equity Interests-99.94%** | **Common Stocks & Other Equity Interests-99.94%** | **Common Stocks & Other Equity Interests-99.94%** |
| **Communication Services-12.37%** | **Communication Services-12.37%** | **Communication Services-12.37%** |
| Bilibili, Inc., ADR (China)<sup>(b)(c)</sup><br>| &nbsp;&nbsp;88217 | &nbsp;&nbsp;&nbsp;&nbsp;$1531447 |
| DISH Network Corp., Class A<sup>(b)</sup><br>| 198602 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3187562 |
| Fox Corp., Class A<br>| 208542 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6767188 |
| Fox Corp., Class B<br>| 165100 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5038852 |
| IAC, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;56741 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2944290 |
| Liberty Broadband Corp., Class C<sup>(b)</sup><br>| &nbsp;&nbsp;89695 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8149688 |
| Liberty Global PLC, Class A (United Kingdom)<sup>(b)</sup><br>| 117967 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2368777 |
| Liberty Global PLC, Class C (United Kingdom)<sup>(b)</sup><br>| 203062 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4199322 |
| Liberty Media Corp.-Liberty Formula One, Class C<sup>(b)</sup><br>| 140487 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8561278 |
| News Corp., Class A<br>| 262373 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5024443 |
| News Corp., Class B<sup>(c)</sup><br>| 133247 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2591654 |
| Paramount Global, Class B<sup>(c)</sup><br>| 413987 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8312859 |
| Playtika Holding Corp.<sup>(b)</sup><br>| 245719 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2322045 |
| Roku, Inc., Class A<sup>(b)(c)</sup><br>| &nbsp;&nbsp;82156 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4877602 |
| Take-Two Interactive Software, Inc.<sup>(b)</sup><br>| 113422 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11987571 |
| Trade Desk, Inc. (The), Class A<sup>(b)</sup><br>| 302130 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15753058 |
| ZoomInfo Technologies, Inc., Class A<sup>(b)</sup><br>| 274511 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7851015 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;101468651 |
| **Consumer Discretionary-13.68%** | **Consumer Discretionary-13.68%** | **Consumer Discretionary-13.68%** |
| Caesars Entertainment, Inc.<sup>(b)</sup><br>| 145897 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7413027 |
| DraftKings, Inc., Class A<sup>(b)(c)</sup><br>| 305208 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4675786 |
| Etsy, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;86143 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11378629 |
| Expedia Group, Inc.<sup>(b)</sup><br>| 103449 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11052491 |
| Hasbro, Inc.<br>| &nbsp;&nbsp;93962 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5902693 |
| Li Auto, Inc., ADR (China)<sup>(b)(c)</sup><br>| 255427 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5619394 |
| LKQ Corp.<br>| 186699 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10143357 |
| Penn Entertainment, Inc.<sup>(b)(c)</sup><br>| 107895 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3796825 |
| Pool Corp.<br>| &nbsp;&nbsp;26943 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8875294 |
| Tractor Supply Co.<br>| &nbsp;&nbsp;75533 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17093873 |
| Trip.com Group Ltd., ADR (China)<sup>(b)(c)</sup><br>| 315691 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10086327 |
| Ulta Beauty, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;34849 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16199209 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;112236905 |
| **Consumer Staples-2.01%** | **Consumer Staples-2.01%** | **Consumer Staples-2.01%** |
| Coca-Cola Europacific Partners PLC (United Kingdom)<br>| 310816 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16501222 |
| **Energy-2.13%** | **Energy-2.13%** | **Energy-2.13%** |
| Diamondback Energy, Inc.<br>| 118021 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17469468 |
| **Health Care-22.47%** | **Health Care-22.47%** | **Health Care-22.47%** |
| 10X Genomics, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;64672 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2500220 |
| Alnylam Pharmaceuticals, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;81673 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18016247 |
| BeiGene Ltd., ADR (China)<sup>(b)(c)</sup><br>| &nbsp;&nbsp;32905 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6304927 |
| BioMarin Pharmaceutical, Inc.<sup>(b)</sup><br>| 126202 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12743878 |
| BioNTech SE, ADR (Germany)<br>| &nbsp;&nbsp;59953 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10013350 |
| Bio-Techne Corp.<br>| 106736 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9071493 |
| Bruker Corp.<br>| 100800 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6794928 |
| DENTSPLY SIRONA, Inc.<br>| 146604 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4436237 |
| Guardant Health, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;69561 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3640823 |
| Hologic, Inc.<sup>(b)</sup><br>| 169878 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12937908 |
| Horizon Therapeutics PLC<sup>(b)(c)</sup><br>| 156767 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15722162 |
| ICON PLC<sup>(b)</sup><br>| &nbsp;&nbsp;55475 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11951534 |
| Incyte Corp.<sup>(b)</sup><br>| 151345 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12057656 |
| Insulet Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;47219 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14135952 |
| Masimo Corp.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;35744 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5180735 |
| Novavax, Inc.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;53226 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;877697 |
| Repligen Corp.<sup>(b)(c)</sup><br>| &nbsp;&nbsp;37753 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6751747 |
| Royalty Pharma PLC, Class A<br>| 297441 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13078481 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Health Care-(continued)** | **Health Care-(continued)** | **Health Care-(continued)** |
| Sanofi, ADR (France)<br>| 197906 | &nbsp;&nbsp;&nbsp;&nbsp;$8975037 |
| Viatris, Inc.<br>| 825076 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9100588 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;184291600 |
| **Industrials-10.80%** | **Industrials-10.80%** | **Industrials-10.80%** |
| American Airlines Group, Inc.<sup>(b)(c)</sup><br>| 442169 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6380499 |
| Axon Enterprise, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;48363 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8900243 |
| C.H. Robinson Worldwide, Inc.<br>| &nbsp;&nbsp;84295 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8448045 |
| CoStar Group, Inc.<sup>(b)</sup><br>| 269419 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21833716 |
| Expeditors International of Washington, Inc.<br>| 111321 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12919915 |
| J.B. Hunt Transport Services, Inc.<br>| &nbsp;&nbsp;70635 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12989070 |
| Lyft, Inc., Class A<sup>(b)</sup><br>| 234169 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2627376 |
| Sunrun, Inc.<sup>(b)(c)</sup><br>| 144316 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4701815 |
| United Airlines Holdings, Inc.<sup>(b)</sup><br>| 222323 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9820007 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;88620686 |
| **Information Technology-32.90%** | **Information Technology-32.90%** | **Information Technology-32.90%** |
| Affirm Holdings, Inc.<sup>(b)(c)</sup><br>| 155793 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2168639 |
| Akamai Technologies, Inc.<sup>(b)</sup><br>| 108165 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10260532 |
| AppLovin Corp., Class A<sup>(b)(c)</sup><br>| 198649 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2862532 |
| Bentley Systems, Inc., Class B<br>| 188328 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7459672 |
| CDW Corp.<br>| &nbsp;&nbsp;92030 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17360539 |
| Check Point Software Technologies Ltd. (Israel)<sup>(b)</sup><br>| &nbsp;&nbsp;85339 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11335579 |
| Cognex Corp.<br>| 117991 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5873592 |
| Coupa Software, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;51405 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3250852 |
| Entegris, Inc.<sup>(c)</sup><br>| 101364 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7834423 |
| F5, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;40521 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6264952 |
| First Solar, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;72536 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12514636 |
| Gen Digital, Inc.<br>| 443204 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10175964 |
| Jack Henry & Associates, Inc.<br>| &nbsp;&nbsp;49610 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9393653 |
| Logitech International S.A., Class R (Switzerland)<sup>(c)</sup><br>| 111345 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6740826 |
| Manhattan Associates, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;42678 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5374867 |
| Monday.com Ltd.<sup>(b)</sup><br>| &nbsp;&nbsp;30684 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3298530 |
| MongoDB, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;46352 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7077487 |
| Monolithic Power Systems, Inc.<br>| &nbsp;&nbsp;31834 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12159315 |
| NetApp, Inc.<br>| 147898 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9999384 |
| ON Semiconductor Corp.<sup>(b)</sup><br>| 294788 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22168058 |
| Open Text Corp. (Canada)<br>| 183590 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5393874 |
| Paylocity Holding Corp.<sup>(b)</sup><br>| &nbsp;&nbsp;37607 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8191933 |
| PTC, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;79923 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10167005 |
| Qorvo, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;70219 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6969236 |
| Seagate Technology Holdings PLC<sup>(c)</sup><br>| 142042 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7523965 |
| SolarEdge Technologies, Inc.<sup>(b)</sup><br>| &nbsp;&nbsp;37852 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11312449 |
| SS&C Technologies Holdings, Inc.<br>| 173522 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9328543 |
| Teradyne, Inc.<br>| 106678 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9969059 |
| Trimble, Inc.<sup>(b)</sup><br>| 168514 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10068711 |
| Western Digital Corp.<sup>(b)</sup><br>| 213992 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7864206 |
| Zebra Technologies Corp., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;35238 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9524127 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;269887140 |
| **Materials-1.58%** | **Materials-1.58%** | **Materials-1.58%** |
| Steel Dynamics, Inc.<br>| 124259 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12914238 |
| **Real Estate-0.83%** | **Real Estate-0.83%** | **Real Estate-0.83%** |
| Opendoor Technologies, Inc.<sup>(b)(c)</sup><br>| 427919 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;791650 |
| Zillow Group, Inc., Class A<sup>(b)</sup><br>| &nbsp;&nbsp;40129 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1500825 |
| Zillow Group, Inc., Class C<sup>(b)(c)</sup><br>| 119739 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4547687 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6840162 |

---

See accompanying notes which are an integral part of this schedule.

------

### Invesco NASDAQ Next Gen 100 ETF (QQQJ)—(continued)<br>
November 30, 2022

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Utilities-1.17%** | **Utilities-1.17%** | **Utilities-1.17%** |
| Alliant Energy Corp.<br>| &nbsp;&nbsp;&nbsp;&nbsp;170734 | &nbsp;&nbsp;&nbsp;&nbsp;$9612324 |
| TOTAL INVESTMENTS IN SECURITIES<br>(excluding investments purchased with cash collateral from securities on loan)-99.94%<br>(Cost $1,037,740,129) | TOTAL INVESTMENTS IN SECURITIES<br>(excluding investments purchased with cash collateral from securities on loan)-99.94%<br>(Cost $1,037,740,129) | &nbsp;&nbsp;819842396 |
| **Investments Purchased with Cash Collateral from Securities on Loan** | **Investments Purchased with Cash Collateral from Securities on Loan** | **Investments Purchased with Cash Collateral from Securities on Loan** |
| **Money Market Funds-12.64%** | **Money Market Funds-12.64%** | **Money Market Funds-12.64%** |
| Invesco Private Government Fund, 3.83%<sup>(d)(e)(f)</sup><br>| 29039081 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29039081 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | &nbsp;&nbsp;**Value** |
| **Money Market Funds-(continued)** | **Money Market Funds-(continued)** | **Money Market Funds-(continued)** |
| Invesco Private Prime Fund, 4.15%<sup>(d)(e)(f)</sup><br>| 74637547 | &nbsp;&nbsp;&nbsp;$74652472 |
| &nbsp;&nbsp;&nbsp;Total Investments Purchased with Cash Collateral from Securities on Loan<br>(Cost $103,678,782) | &nbsp;&nbsp;&nbsp;Total Investments Purchased with Cash Collateral from Securities on Loan<br>(Cost $103,678,782) | &nbsp;&nbsp;&nbsp;103691553 |
| TOTAL INVESTMENTS IN SECURITIES-112.58%<br>(Cost $1,141,418,911) | TOTAL INVESTMENTS IN SECURITIES-112.58%<br>(Cost $1,141,418,911) | &nbsp;&nbsp;&nbsp;923533949 |
| OTHER ASSETS LESS LIABILITIES-(12.58)% | OTHER ASSETS LESS LIABILITIES-(12.58)% | &nbsp;&nbsp;(103170972) |
| NET ASSETS-100.00% | NET ASSETS-100.00% | $820362977 |

---

Investment Abbreviations: <br> ADR -American Depositary Receipt

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is the exclusive property and a service mark of MSCI Inc. and Standard & Poor's. |
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at November 30, 2022. |
| <sup>(d)</sup> | Affiliated issuer. The issuer and/or the Fund is a wholly-owned subsidiary of Invesco Ltd., or is affiliated by having an investment adviser that is under common control of Invesco Ltd. The table below shows the Fund's transactions in, and earnings from, its investments in affiliates for the three months ended November 30, 2022. |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;&nbsp;**Value<br> August 31, 2022** | &nbsp;&nbsp;&nbsp;**Purchases<br> at Cost** | &nbsp;&nbsp;&nbsp;**Proceeds<br> from Sales** | &nbsp;&nbsp;&nbsp;**Change in<br> Unrealized<br> Appreciation** | &nbsp;&nbsp;&nbsp;**Realized<br> Gain** | &nbsp;&nbsp;&nbsp;**Value<br> November 30, 2022** | &nbsp;&nbsp;&nbsp;**Dividend<br> Income** |
| &nbsp;&nbsp;**Investments in Affiliated Money Market Funds:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Invesco Government & Agency Portfolio, Institutional Class | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;&nbsp;$1770003 | &nbsp;&nbsp;&nbsp;&nbsp;$(1770003) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;&nbsp;$1900 |
| &nbsp;&nbsp;**Investments Purchased with Cash Collateral from Securities on Loan:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Invesco Private Government Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29805913 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;85332935 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(86099767) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29039081 | &nbsp;&nbsp;&nbsp;&nbsp;229,018\* |
| &nbsp;&nbsp;Invesco Private Prime Fund | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;85560046 | &nbsp;&nbsp;&nbsp;&nbsp;165984402 | &nbsp;&nbsp;&nbsp;&nbsp;(176905972) | &nbsp;&nbsp;&nbsp;&nbsp;4587 | &nbsp;&nbsp;&nbsp;&nbsp;9409 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;74652472 | &nbsp;&nbsp;&nbsp;&nbsp;634,340\* |
| &nbsp;&nbsp;Total | &nbsp;&nbsp;&nbsp;$115365959 | &nbsp;&nbsp;&nbsp;$253087340 | &nbsp;&nbsp;&nbsp;$(264775742) | &nbsp;&nbsp;&nbsp;$4587 | &nbsp;&nbsp;&nbsp;$9409 | &nbsp;&nbsp;&nbsp;$103691553 | &nbsp;&nbsp;&nbsp;$865258 |

---

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of November 30, 2022. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

### Notes to Quarterly Schedules of Portfolio Holdings
November 30, 2022

(Unaudited)

#### NOTE 1—Additional Valuation Information
Generally Accepted Accounting Principles ("GAAP") defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, under current market conditions. GAAP establishes a hierarchy that prioritizes the inputs to valuation methods, giving the highest priority to readily available unadjusted quoted prices in an active market for identical assets (Level 1) and the lowest priority to significant unobservable inputs (Level 3), generally when market prices are not readily available. Based on the valuation inputs, the securities or other investments are tiered into one of three levels. Changes in valuation methods may result in transfers in or out of an investment's assigned level:

Level 1 — Prices are determined using quoted prices in an active market for identical assets.

Level 2 — Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants may use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk, yield curves, loss severities, default rates, discount rates, volatilities and others.

Level 3 — Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used. Unobservable inputs reflect Invesco Capital Management LLC's assumptions about the factors market participants would use in determining fair value of the securities or instruments and would be based on the best available information.

The following is a summary of the tiered valuation input levels, as of November 30, 2022. The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities. Because of the inherent uncertainties of valuation, the values reflected in the financial statements may materially differ from the value received upon actual sale of those investments.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;&nbsp;**Level 1** | &nbsp;&nbsp;&nbsp;**Level 2** | &nbsp;&nbsp;&nbsp;**Level 3** | &nbsp;&nbsp;&nbsp;**Total** |
| &nbsp;&nbsp;Invesco ESG NASDAQ 100 ETF |  |  |  |  |
| &nbsp;&nbsp;**Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$9922314 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$9922314 |
| &nbsp;&nbsp;&nbsp;Money Market Funds | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1471 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;35650 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;37121 |
| &nbsp;&nbsp;&nbsp;**Total Investments** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$9923785 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$35650 | &nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$9959435 |
| &nbsp;&nbsp;Invesco ESG NASDAQ Next Gen 100 ETF |  |  |  |  |
| &nbsp;&nbsp;**Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$2829816 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$2829816 |
| &nbsp;&nbsp;&nbsp;Money Market Funds | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;188170 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;188170 |
| &nbsp;&nbsp;&nbsp;**Total Investments** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$2829816 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$188170 | &nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$3017986 |
| &nbsp;&nbsp;Invesco NASDAQ 100 ETF |  |  |  |  |
| &nbsp;&nbsp;**Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp;$6020085752 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$6020085752 |
| &nbsp;&nbsp;&nbsp;Money Market Funds | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;71483300 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;71483300 |
| &nbsp;&nbsp;&nbsp;**Total Investments** | &nbsp;&nbsp;&nbsp;$6020085752 | &nbsp;&nbsp;&nbsp;$71483300 | &nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$6091569052 |
| &nbsp;&nbsp;Invesco NASDAQ Future Gen 200 ETF |  |  |  |  |
| &nbsp;&nbsp;**Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$4733464 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$4733464 |
| &nbsp;&nbsp;&nbsp;Money Market Funds | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1144 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1144 |
| &nbsp;&nbsp;&nbsp;**Total Investments** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$4734608 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$4734608 |
| &nbsp;&nbsp;Invesco NASDAQ Next Gen 100 ETF |  |  |  |  |
| &nbsp;&nbsp;**Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp;$819842396 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$819842396 |
| &nbsp;&nbsp;&nbsp;Money Market Funds | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;103691553 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;103691553 |
| &nbsp;&nbsp;&nbsp;**Total Investments** | &nbsp;&nbsp;&nbsp;$819842396 | &nbsp;&nbsp;&nbsp;$103691553 | &nbsp;&nbsp;&nbsp;$- | &nbsp;&nbsp;&nbsp;$923533949 |

---

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Invesco Exchange-Traded Fund Trust II

- **b. Investment Company Act file number:** 811-21977

- **c. CIK number of Registrant:** 0001378872

- **d. LEI of Registrant:** O540V2L4S174Y60FMD36

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 3500 Lacey Road

  - **City:** Downers Grove

  - **State:** IL

  - **Foreign country:** US

  - **Zip / Postal Code:** 60515

  - **Telephone number:** 800-983-0903

**Item A.2. Information about the Series.**

- **a. Name of Series:** Invesco NASDAQ Future Gen 200 ETF

- **b. EDGAR series identifier (if any):** S000077288

- **c. LEI of Series:** 549300GPI35ZCTF27915

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-08-31

- **b. Date as of which information is reported:** 2022-11-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $4734867.89

**Total Liabilities:** $657.40

**Net Assets:** $4734210.49

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000237581 |  | 6.71%                | 2.99%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $0.00                    | $0.00                                      |
| Month 2  | $12.05                   | $250299.57                                 |
| Month 3  | $118.58                  | $124595.39                                 |

### Schedule of Portfolio Investments

| Name                                    | Title                                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| MannKind Corp.                          | MannKind Corp.                                             | CUSIP: 56400P706<br>LEI: 213800GFBCNY1ZFST722 | Long             | EC               | CORP              | US        |      6870 | NS      | $32151.60     | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| InterDigital, Inc.                      | InterDigital, Inc.                                         | CUSIP: 45867G101<br>LEI: 529900HQAUTC3VI47G64 | Long             | EC               | CORP              | US        |       494 | NS      | $24783.98     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Sonos, Inc.                             | Sonos, Inc.                                                | CUSIP: 83570H108<br>LEI: 549300WEPU6075I77M08 | Long             | EC               | CORP              | US        |      1650 | NS      | $28924.50     | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Bicycle Therapeutics PLC                | Bicycle Therapeutics PLC, ADR                              | CUSIP: 088786108<br>LEI: 213800XKUI6R7GKC3E43 | Long             | EC               | CORP              | GB        |       937 | NS      | $27135.52     | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Viasat, Inc.                            | Viasat, Inc.                                               | CUSIP: 92552V100<br>LEI: UFC8NYMNFSYIHNSM2I38 | Long             | EC               | CORP              | US        |       662 | NS      | $22567.58     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Ionis Pharmaceuticals, Inc.             | Ionis Pharmaceuticals, Inc.                                | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |       582 | NS      | $23739.78     | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Heron Therapeutics, Inc.                | Heron Therapeutics, Inc.                                   | CUSIP: 427746102<br>LEI: 549300DR2I1DOPD2IX53 | Long             | EC               | CORP              | US        |      6069 | NS      | $16446.99     | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Garrett Motion Inc.                     | Garrett Motion Inc.                                        | CUSIP: 366505105<br>LEI: 549300LS5WT7EMBNV724 | Long             | EC               | CORP              | US        |      3642 | NS      | $25785.36     | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Sierra Wireless, Inc.                   | Sierra Wireless, Inc.                                      | CUSIP: 826516106<br>LEI: 549300E33RZ5BJ726L53 | Long             | EC               | CORP              | CA        |       816 | NS      | $23933.28     | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| uniQure N.V.                            | uniQure N.V.                                               | CUSIP: N90064101<br>LEI: 724500RPCTZLFYJZ3S98 | Long             | EC               | CORP              | NL        |      1272 | NS      | $33657.12     | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Aviat Networks, Inc.                    | Aviat Networks, Inc.                                       | CUSIP: 05366Y201<br>LEI: 549300Z3X8Z4MK52CI65 | Long             | EC               | CORP              | US        |       802 | NS      | $25230.92     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| TrueCar, Inc.                           | TrueCar, Inc.                                              | CUSIP: 89785L107<br>LEI: 549300KK16488YXWVE52 | Long             | EC               | CORP              | US        |     11493 | NS      | $28617.57     | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Ligand Pharmaceuticals Inc.             | Ligand Pharmaceuticals Inc.                                | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |       272 | NS      | $19828.80     | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Gentex Corp.                            | Gentex Corp.                                               | CUSIP: 371901109<br>LEI: 549300S3UD8XV1MN0287 | Long             | EC               | CORP              | US        |       907 | NS      | $26212.30     | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Amarin Corp. PLC                        | Amarin Corp. PLC, ADR                                      | CUSIP: 023111206<br>LEI: 5493009JFIGUFEVPK217 | Long             | EC               | CORP              | GB        |     21274 | NS      | $24465.10     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Infinera Corp.                          | Infinera Corp.                                             | CUSIP: 45667G103<br>LEI: 549300ZOF66WPV3H0H17 | Long             | EC               | CORP              | US        |      4575 | NS      | $30881.25     | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Spectrum Pharmaceuticals, Inc.          | Spectrum Pharmaceuticals, Inc.                             | CUSIP: 84763A108<br>LEI: 549300COU30WSP3O5I07 | Long             | EC               | CORP              | US        |     22502 | NS      | $10364.42     | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| ICU Medical, Inc.                       | ICU Medical, Inc.                                          | CUSIP: 44930G107<br>LEI: 5493003NRW7LS2QZRH60 | Long             | EC               | CORP              | US        |       157 | NS      | $24999.11     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Lattice Semiconductor Corp.             | Lattice Semiconductor Corp.                                | CUSIP: 518415104<br>LEI: 549300LRBBPZDQ2II567 | Long             | EC               | CORP              | US        |       464 | NS      | $33793.12     | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Axcelis Technologies, Inc.              | Axcelis Technologies, Inc.                                 | CUSIP: 054540208<br>LEI: 529900HF9B6NL1QG9F05 | Long             | EC               | CORP              | US        |       371 | NS      | $29628.06     | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Avadel Pharmaceuticals PLC              | Avadel Pharmaceuticals PLC, ADR                            | CUSIP: 05337M104<br>LEI: 549300E27PTSG2RHC762 | Long             | EC               | CORP              | IE        |      3740 | NS      | $34295.80     | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Vuzix Corp.                             | Vuzix Corp.                                                | CUSIP: 92921W300<br>LEI: 549300EWPW64TZQXJG66 | Long             | EC               | CORP              | US        |      3297 | NS      | $13748.49     | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Kopin Corp.                             | Kopin Corp.                                                | CUSIP: 500600101<br>LEI: 52990031GUBB61RXCD89 | Long             | EC               | CORP              | US        |     18092 | NS      | $29309.04     | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| 22nd Century Group, Inc.                | 22nd Century Group, Inc.                                   | CUSIP: 90137F103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18481 | NS      | $21807.58     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Merus N.V.                              | Merus N.V.                                                 | CUSIP: N5749R100<br>LEI: 549300W8GPUWU8QNU293 | Long             | EC               | CORP              | NL        |      1064 | NS      | $16332.40     | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Varex Imaging Corp.                     | Varex Imaging Corp.                                        | CUSIP: 92214X106<br>LEI: 549300CWYWPVCT8E9W67 | Long             | EC               | CORP              | US        |      1175 | NS      | $24957.00     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Bionano Genomics, Inc.                  | Bionano Genomics, Inc.                                     | CUSIP: 09075F107<br>LEI: 54930086AP7ROH0VJ631 | Long             | EC               | CORP              | US        |     10121 | NS      | $20343.21     | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Sesen Bio, Inc.                         | Sesen Bio, Inc.                                            | CUSIP: 817763105<br>LEI: 549300DGKHONOZQIY116 | Long             | EC               | CORP              | US        |     35907 | NS      | $19885.30     | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Adtran Holdings, Inc.                   | Adtran Holdings, Inc.                                      | CUSIP: 00486H105<br>LEI: 549300VV36J86CRRWF77 | Long             | EC               | CORP              | US        |      1082 | NS      | $21932.14     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Amyris, Inc.                            | Amyris, Inc.                                               | CUSIP: 03236M200<br>LEI: 549300BG17WCUK6EIM58 | Long             | EC               | CORP              | US        |      8433 | NS      | $14589.09     | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Intercept Pharmaceuticals, Inc.         | Intercept Pharmaceuticals, Inc.                            | CUSIP: 45845P108<br>LEI: 254900JMB8TX5P688V24 | Long             | EC               | CORP              | US        |      1427 | NS      | $21276.57     | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Compugen Ltd.                           | Compugen Ltd.                                              | CUSIP: M25722105<br>LEI: N/A                  | Long             | EC               | CORP              | IL        |     21167 | NS      | $25400.40     | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Oramed Pharmaceuticals Inc.             | Oramed Pharmaceuticals Inc.                                | CUSIP: 68403P203<br>LEI: 5299006K52ZIIGQJ6R84 | Long             | EC               | CORP              | US        |      2895 | NS      | $24462.75     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| OmniAb, Inc.                            | OmniAb, Inc.                                               | CUSIP: 68218J301<br>LEI: N/A                  | Long             | EC               | CORP              | US        |        83 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| American Superconductor Corp.           | American Superconductor Corp.                              | CUSIP: 030111207<br>LEI: 549300S9YT8Z8LOK4452 | Long             | EC               | CORP              | US        |      4640 | NS      | $17446.40     | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Stratasys Ltd.                          | Stratasys Ltd.                                             | CUSIP: M85548101<br>LEI: 529900MU215GIP9SZ741 | Long             | EC               | CORP              | IL        |      1434 | NS      | $20119.02     | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Universal Electronics Inc.              | Universal Electronics Inc.                                 | CUSIP: 913483103<br>LEI: 549300ZW9EULAR7T6F89 | Long             | EC               | CORP              | US        |      1116 | NS      | $24406.92     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| SunPower Corp.                          | SunPower Corp.                                             | CUSIP: 867652406<br>LEI: 549300TXO070764WUH65 | Long             | EC               | CORP              | US        |      1047 | NS      | $25389.75     | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Comtech Telecommunications Corp.        | Comtech Telecommunications Corp.                           | CUSIP: 205826209<br>LEI: 529900FTEZ8MGM0Y8F73 | Long             | EC               | CORP              | US        |      2195 | NS      | $25615.65     | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Dare Bioscience Inc.                    | Dare Bioscience Inc.                                       | CUSIP: 23666P101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     23256 | NS      | $20700.17     | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Merit Medical Systems, Inc.             | Merit Medical Systems, Inc.                                | CUSIP: 589889104<br>LEI: 549300OYTY138SP2CE83 | Long             | EC               | CORP              | US        |       421 | NS      | $30312.00     | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Lantronix, Inc.                         | Lantronix, Inc.                                            | CUSIP: 516548203<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4092 | NS      | $20951.04     | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Ironwood Pharmaceuticals, Inc.          | Ironwood Pharmaceuticals, Inc.                             | CUSIP: 46333X108<br>LEI: 549300PC8MR6QHH6P296 | Long             | EC               | CORP              | US        |      2332 | NS      | $28240.52     | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Invesco Government & Agency Portfolio   | Invesco Government & Agency Portfolio, Institutional Class | CUSIP: 825252885<br>LEI: 5493007T1J7WZ5QI1A47 | Long             | STIV             | RF                | US        |      1144 | NS      | $1144.13      | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Dropbox, Inc.                           | Dropbox, Inc., Class A                                     | CUSIP: 26210C104<br>LEI: 549300JCDF7UAR6TJR51 | Long             | EC               | CORP              | US        |      1159 | NS      | $27306.04     | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Haynes International, Inc.              | Haynes International, Inc.                                 | CUSIP: 420877201<br>LEI: 549300I9MS5UZLRFDO40 | Long             | EC               | CORP              | US        |       626 | NS      | $31274.96     | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Materialise N.V.                        | Materialise N.V., ADR                                      | CUSIP: 57667T100<br>LEI: 5493004CXYDPCZ5RQK28 | Long             | EC               | CORP              | BE        |      2121 | NS      | $20467.65     | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| ClearPoint Neuro, Inc.                  | ClearPoint Neuro, Inc.                                     | CUSIP: 18507C103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1924 | NS      | $18143.32     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| OraSure Technologies, Inc.              | OraSure Technologies, Inc.                                 | CUSIP: 68554V108<br>LEI: 529900GNNJPNM4XHXQ77 | Long             | EC               | CORP              | US        |      6124 | NS      | $30864.96     | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Accuray Inc.                            | Accuray Inc.                                               | CUSIP: 004397105<br>LEI: 549300G28LY4TZKZJG51 | Long             | EC               | CORP              | US        |     10554 | NS      | $21635.70     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Silk Road Medical, Inc.                 | Silk Road Medical, Inc.                                    | CUSIP: 82710M100<br>LEI: 549300VL8KC0ZPDQHE14 | Long             | EC               | CORP              | US        |       625 | NS      | $33281.25     | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Standard Biotools Inc.                  | Standard Biotools Inc.                                     | CUSIP: 34385P108<br>LEI: 549300GX8Y96GSB6YP89 | Long             | EC               | CORP              | US        |     17813 | NS      | $24760.07     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| MacroGenics, Inc.                       | MacroGenics, Inc.                                          | CUSIP: 556099109<br>LEI: 5493001KJQUA83L8MH79 | Long             | EC               | CORP              | US        |      6254 | NS      | $40213.22     | 0.85%             |  |  |  | No            |                  1 | On Loan: No      |
| Lumentum Holdings Inc.                  | Lumentum Holdings Inc.                                     | CUSIP: 55024U109<br>LEI: 549300JLWRRC38DWEF52 | Long             | EC               | CORP              | US        |       302 | NS      | $16591.88     | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| FibroGen, Inc.                          | FibroGen, Inc.                                             | CUSIP: 31572Q808<br>LEI: 549300Q914ULWWY95822 | Long             | EC               | CORP              | US        |      2016 | NS      | $28969.92     | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Nektar Therapeutics                     | Nektar Therapeutics                                        | CUSIP: 640268108<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |      6293 | NS      | $17620.40     | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Reata Pharmaceuticals, Inc.             | Reata Pharmaceuticals, Inc., Class A                       | CUSIP: 75615P103<br>LEI: 5299005F094GH9QDDD80 | Long             | EC               | CORP              | US        |      1048 | NS      | $41479.84     | 0.88%             |  |  |  | No            |                  1 | On Loan: No      |
| IPG Photonics Corp.                     | IPG Photonics Corp.                                        | CUSIP: 44980X109<br>LEI: 5493002KZ51CADQ94G15 | Long             | EC               | CORP              | US        |       276 | NS      | $25124.28     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Theravance Biopharma, Inc.              | Theravance Biopharma, Inc., Class B                        | CUSIP: G8807B106<br>LEI: 5493007VTSXP4Z6MIW52 | Long             | EC               | CORP              | KY        |      2754 | NS      | $29633.04     | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Rigel Pharmaceuticals, Inc.             | Rigel Pharmaceuticals, Inc.                                | CUSIP: 766559603<br>LEI: 529900KPTNUS5J8K9K66 | Long             | EC               | CORP              | US        |     17802 | NS      | $11955.82     | 0.25%             |  |  |  | No            |                  1 | On Loan: No      |
| bluebird bio, Inc.                      | bluebird bio, Inc.                                         | CUSIP: 09609G100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4248 | NS      | $33091.92     | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Kimball Electronics, Inc.               | Kimball Electronics, Inc.                                  | CUSIP: 49428J109<br>LEI: 549300COBYN2GZCBIU87 | Long             | EC               | CORP              | US        |      1166 | NS      | $26922.94     | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Precision BioSciences, Inc.             | Precision BioSciences, Inc.                                | CUSIP: 74019P108<br>LEI: 549300I5QGRS3BLHZH41 | Long             | EC               | CORP              | US        |     15390 | NS      | $21084.30     | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Viavi Solutions Inc.                    | Viavi Solutions Inc.                                       | CUSIP: 925550105<br>LEI: 5493006K3E3N1QOBF092 | Long             | EC               | CORP              | US        |      1765 | NS      | $19997.45     | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Turtle Beach Corp.                      | Turtle Beach Corp.                                         | CUSIP: 900450206<br>LEI: 549300SZRV8U8PXSYI20 | Long             | EC               | CORP              | US        |      2637 | NS      | $25183.35     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Interface, Inc.                         | Interface, Inc.                                            | CUSIP: 458665304<br>LEI: 549300VXZWQOIDFPU355 | Long             | EC               | CORP              | US        |      2247 | NS      | $24335.01     | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| LivePerson, Inc.                        | LivePerson, Inc.                                           | CUSIP: 538146101<br>LEI: 549300IN2P1JZ20G7N40 | Long             | EC               | CORP              | US        |      2137 | NS      | $25088.38     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Verastem, Inc.                          | Verastem, Inc.                                             | CUSIP: 92337C104<br>LEI: 549300IY0EFBIU8NQC81 | Long             | EC               | CORP              | US        |     21891 | NS      | $10069.86     | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| CommScope Holding Co., Inc.             | CommScope Holding Co., Inc.                                | CUSIP: 20337X109<br>LEI: 254900AW4CEPCQWSRI58 | Long             | EC               | CORP              | US        |      2194 | NS      | $19482.72     | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| OmniAb, Inc.                            | OmniAb, Inc.                                               | CUSIP: 68218J103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1309 | NS      | $4633.86      | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Sutro Biopharma, Inc.                   | Sutro Biopharma, Inc.                                      | CUSIP: 869367102<br>LEI: 5493005U6P15VD25P851 | Long             | EC               | CORP              | US        |      4386 | NS      | $32851.14     | 0.69%             |  |  |  | No            |                  1 | On Loan: No      |
| SI-BONE, Inc.                           | SI-BONE, Inc.                                              | CUSIP: 825704109<br>LEI: 549300J8JGYVJJHV9C31 | Long             | EC               | CORP              | US        |      1500 | NS      | $18420.00     | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Pieris Pharmaceuticals, Inc.            | Pieris Pharmaceuticals, Inc.                               | CUSIP: 720795103<br>LEI: 254900AJDH8PAOOI5T33 | Long             | EC               | CORP              | US        |     16965 | NS      | $16549.36     | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Power Integrations, Inc.                | Power Integrations, Inc.                                   | CUSIP: 739276103<br>LEI: 54930085LGXSCIHD5W31 | Long             | EC               | CORP              | US        |       351 | NS      | $28248.48     | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Prothena Corp. PLC                      | Prothena Corp. PLC                                         | CUSIP: G72800108<br>LEI: 5299009ZXQ8NIIJ8OL30 | Long             | EC               | CORP              | IE        |       906 | NS      | $56634.06     | 1.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Gentherm Inc.                           | Gentherm Inc.                                              | CUSIP: 37253A103<br>LEI: HKM6YX1U5JS60TCUB219 | Long             | EC               | CORP              | US        |       419 | NS      | $29996.21     | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Mitek Systems, Inc.                     | Mitek Systems, Inc.                                        | CUSIP: 606710200<br>LEI: 549300ABZAQ3R25XG118 | Long             | EC               | CORP              | US        |      2429 | NS      | $24848.67     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Coherus BioSciences, Inc.               | Coherus BioSciences, Inc.                                  | CUSIP: 19249H103<br>LEI: 5493007IL8W5MV932D26 | Long             | EC               | CORP              | US        |      2217 | NS      | $15208.62     | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| SecureWorks Corp.                       | SecureWorks Corp., Class A                                 | CUSIP: 81374A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2381 | NS      | $17095.58     | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Enanta Pharmaceuticals, Inc.            | Enanta Pharmaceuticals, Inc.                               | CUSIP: 29251M106<br>LEI: 529900SSN4DODDQSN594 | Long             | EC               | CORP              | US        |       408 | NS      | $17866.32     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Amicus Therapeutics, Inc.               | Amicus Therapeutics, Inc.                                  | CUSIP: 03152W109<br>LEI: 549300MRD1SMUTNBPQ53 | Long             | EC               | CORP              | US        |      2210 | NS      | $26741.00     | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Alpha and Omega Semiconductor Ltd.      | Alpha and Omega Semiconductor Ltd.                         | CUSIP: G6331P104<br>LEI: 5493001FE7J03YOV2V35 | Long             | EC               | CORP              | BM        |       642 | NS      | $22521.36     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC Therapeutics, Inc.                  | PTC Therapeutics, Inc.                                     | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |       495 | NS      | $20537.55     | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Seres Therapeutics, Inc.                | Seres Therapeutics, Inc.                                   | CUSIP: 81750R102<br>LEI: 549300GMXBE5NUWISF13 | Long             | EC               | CORP              | US        |      4876 | NS      | $31694.00     | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Amkor Technology, Inc.                  | Amkor Technology, Inc.                                     | CUSIP: 031652100<br>LEI: 529900VHLRTKPWZJBM84 | Long             | EC               | CORP              | US        |      1244 | NS      | $34856.88     | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| AtriCure, Inc.                          | AtriCure, Inc.                                             | CUSIP: 04963C209<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       549 | NS      | $25012.44     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Codexis, Inc.                           | Codexis, Inc.                                              | CUSIP: 192005106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3535 | NS      | $19336.45     | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Astronics Corp.                         | Astronics Corp.                                            | CUSIP: 046433108<br>LEI: 549300NNXCF8H4MSMK17 | Long             | EC               | CORP              | US        |      2689 | NS      | $22587.60     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Universal Display Corp.                 | Universal Display Corp.                                    | CUSIP: 91347P105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       224 | NS      | $25226.88     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Eagle Pharmaceuticals, Inc.             | Eagle Pharmaceuticals, Inc.                                | CUSIP: 269796108<br>LEI: 549300TN20OLYTJVP152 | Long             | EC               | CORP              | US        |       761 | NS      | $27639.52     | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Cardiovascular Systems, Inc.            | Cardiovascular Systems, Inc.                               | CUSIP: 141619106<br>LEI: 549300NUBWKJMNMQ3287 | Long             | EC               | CORP              | US        |      1900 | NS      | $26619.00     | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Surmodics, Inc.                         | Surmodics, Inc.                                            | CUSIP: 868873100<br>LEI: 549300H76KXCAAGUS878 | Long             | EC               | CORP              | US        |       735 | NS      | $26555.55     | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Tactile Systems Technology, Inc.        | Tactile Systems Technology, Inc.                           | CUSIP: 87357P100<br>LEI: 54930069VDTITHOTKJ98 | Long             | EC               | CORP              | US        |      3044 | NS      | $26056.64     | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| UroGen Pharma Ltd.                      | UroGen Pharma Ltd.                                         | CUSIP: M96088105<br>LEI: 549300C0YCX7CG2G5D50 | Long             | EC               | CORP              | IL        |      3369 | NS      | $28872.33     | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Apyx Medical Corp.                      | Apyx Medical Corp.                                         | CUSIP: 03837C106<br>LEI: 5299009QZVYUYO082S45 | Long             | EC               | CORP              | US        |      4325 | NS      | $7612.00      | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Lexicon Pharmaceuticals, Inc.           | Lexicon Pharmaceuticals, Inc.                              | CUSIP: 528872302<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8999 | NS      | $19257.86     | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| OPKO Health, Inc.                       | OPKO Health, Inc.                                          | CUSIP: 68375N103<br>LEI: 529900A4S2D4OGOJLL02 | Long             | EC               | CORP              | US        |     11367 | NS      | $17050.50     | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacific Biosciences of California, Inc. | Pacific Biosciences of California, Inc.                    | CUSIP: 69404D108<br>LEI: 529900F1BWRE1M0KZN89 | Long             | EC               | CORP              | US        |      4269 | NS      | $45891.75     | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| VOXX International Corp.                | VOXX International Corp.                                   | CUSIP: 91829F104<br>LEI: EC1QKSEOVR96PYJPNS25 | Long             | EC               | CORP              | US        |      2604 | NS      | $28617.96     | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Xencor, Inc.                            | Xencor, Inc.                                               | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |       951 | NS      | $28263.72     | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Littelfuse, Inc.                        | Littelfuse, Inc.                                           | CUSIP: 537008104<br>LEI: 549300MY7HLQFYTPCX75 | Long             | EC               | CORP              | US        |       104 | NS      | $25636.00     | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Sangamo Therapeutics, Inc.              | Sangamo Therapeutics, Inc.                                 | CUSIP: 800677106<br>LEI: 2549006WMRKRC4G32Z67 | Long             | EC               | CORP              | US        |      4592 | NS      | $16806.72     | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Immersion Corp.                         | Immersion Corp.                                            | CUSIP: 452521107<br>LEI: 529900AKNC1UAMQ2YB35 | Long             | EC               | CORP              | US        |      4160 | NS      | $30201.60     | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| LivaNova PLC                            | LivaNova PLC                                               | CUSIP: G5509L101<br>LEI: 2138001K2FX6SHK2B339 | Long             | EC               | CORP              | GB        |       441 | NS      | $24418.17     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Karyopharm Therapeutics Inc.            | Karyopharm Therapeutics Inc.                               | CUSIP: 48576U106<br>LEI: 549300J1VANRCNTYST87 | Long             | EC               | CORP              | US        |      4910 | NS      | $25973.90     | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| EMCORE Corp.                            | EMCORE Corp.                                               | CUSIP: 290846203<br>LEI: 529900B9OHDEWU534K08 | Long             | EC               | CORP              | US        |     10422 | NS      | $14799.24     | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Sleep Number Corp.                      | Sleep Number Corp.                                         | CUSIP: 83125X103<br>LEI: 529900W0TZQLBT2DSS66 | Long             | EC               | CORP              | US        |       598 | NS      | $17491.50     | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Agios Pharmaceuticals, Inc.             | Agios Pharmaceuticals, Inc.                                | CUSIP: 00847X104<br>LEI: 529900ONJHY8EOGYT555 | Long             | EC               | CORP              | US        |       984 | NS      | $29657.76     | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Edgio Inc.                              | Edgio Inc.                                                 | CUSIP: 53261M104<br>LEI: 529900BNCMDQGEKW5M59 | Long             | EC               | CORP              | US        |      6736 | NS      | $9699.84      | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilat Satellite Networks Ltd.           | Gilat Satellite Networks Ltd.                              | CUSIP: N/A<br>LEI: 529900RVHDCYJ5YWHP12       | Long             | EC               | CORP              | IL        |      3774 | NS      | $23323.32     | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Extreme Networks, Inc.                  | Extreme Networks, Inc.                                     | CUSIP: 30226D106<br>LEI: 549300WRECW11X94UB57 | Long             | EC               | CORP              | US        |      1749 | NS      | $36676.53     | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Aehr Test Systems                       | Aehr Test Systems                                          | CUSIP: 00760J108<br>LEI: 529900A4GWWZFRU2RE97 | Long             | EC               | CORP              | US        |      1721 | NS      | $44866.47     | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| CymaBay Therapeutics, Inc.              | CymaBay Therapeutics, Inc.                                 | CUSIP: 23257D103<br>LEI: 549300YT9GNL852E7F84 | Long             | EC               | CORP              | US        |      7017 | NS      | $23717.46     | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Azenta Inc.                             | Azenta Inc.                                                | CUSIP: 114340102<br>LEI: 35ZN6X1ANPH25YN32Y17 | Long             | EC               | CORP              | US        |       471 | NS      | $28358.91     | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Atomera Inc.                            | Atomera Inc.                                               | CUSIP: 04965B100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1916 | NS      | $16343.48     | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| GoPro, Inc.                             | GoPro, Inc.                                                | CUSIP: 38268T103<br>LEI: 549300CQJMLT21SZFL16 | Long             | EC               | CORP              | US        |      4070 | NS      | $22303.60     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Goodyear Tire & Rubber Co. (The)        | Goodyear Tire & Rubber Co. (The)                           | CUSIP: 382550101<br>LEI: 5493002BI0S2ZQUY3437 | Long             | EC               | CORP              | US        |      1767 | NS      | $19825.74     | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Orthofix Medical Inc.                   | Orthofix Medical Inc.                                      | CUSIP: 68752M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1245 | NS      | $22397.55     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Chimerix, Inc.                          | Chimerix, Inc.                                             | CUSIP: 16934W106<br>LEI: 5299002IR2GXUBEPKS66 | Long             | EC               | CORP              | US        |     11273 | NS      | $24462.41     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| ViewRay, Inc.                           | ViewRay, Inc.                                              | CUSIP: 92672L107<br>LEI: 5493006XTUBSKFU3W106 | Long             | EC               | CORP              | US        |      7327 | NS      | $35316.14     | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| NuVasive, Inc.                          | NuVasive, Inc.                                             | CUSIP: 670704105<br>LEI: 549300C5ZB4NZ6TWM881 | Long             | EC               | CORP              | US        |       582 | NS      | $22604.88     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Geron Corp.                             | Geron Corp.                                                | CUSIP: 374163103<br>LEI: 549300T282D7Z2YESL90 | Long             | EC               | CORP              | US        |      9383 | NS      | $21768.56     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Vanda Pharmaceuticals Inc.              | Vanda Pharmaceuticals Inc.                                 | CUSIP: 921659108<br>LEI: 529900AY8VOOQBKJ0O70 | Long             | EC               | CORP              | US        |      2373 | NS      | $25889.43     | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| NanoString Technologies, Inc.           | NanoString Technologies, Inc.                              | CUSIP: 63009R109<br>LEI: 549300G4CK0Y3WRDMY89 | Long             | EC               | CORP              | US        |      1830 | NS      | $12791.70     | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Selecta Biosciences, Inc.               | Selecta Biosciences, Inc.                                  | CUSIP: 816212104<br>LEI: 529900NMN0LACZOL7C43 | Long             | EC               | CORP              | US        |     13182 | NS      | $17268.42     | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Clovis Oncology, Inc.                   | Clovis Oncology, Inc.                                      | CUSIP: 189464100<br>LEI: 529900WCUY9ZAHMRV489 | Long             | EC               | CORP              | US        |     22169 | NS      | $7315.77      | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Revance Therapeutics, Inc.              | Revance Therapeutics, Inc.                                 | CUSIP: 761330109<br>LEI: 549300N33TFDZHS81H11 | Long             | EC               | CORP              | US        |      1260 | NS      | $27354.60     | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| CalAmp Corp.                            | CalAmp Corp.                                               | CUSIP: 128126109<br>LEI: 5493007SIGZIX83TOW07 | Long             | EC               | CORP              | US        |      4015 | NS      | $14494.15     | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Synaptics Inc.                          | Synaptics Inc.                                             | CUSIP: 87157D109<br>LEI: 549300AJ3LI4FWNRQX29 | Long             | EC               | CORP              | US        |       215 | NS      | $22783.55     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Smith Micro Software, Inc.              | Smith Micro Software, Inc.                                 | CUSIP: 832154207<br>LEI: 549300YR8UTB5CX2B814 | Long             | EC               | CORP              | US        |     10204 | NS      | $22959.00     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Itron, Inc.                             | Itron, Inc.                                                | CUSIP: 465741106<br>LEI: 24F6LSZD18II6ICG6S41 | Long             | EC               | CORP              | US        |       522 | NS      | $27759.96     | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| MKS Instruments, Inc.                   | MKS Instruments, Inc.                                      | CUSIP: 55306N104<br>LEI: 549300KEQATBHAGVF505 | Long             | EC               | CORP              | US        |       250 | NS      | $20965.00     | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Flex Ltd.                               | Flex Ltd.                                                  | CUSIP: Y2573F102<br>LEI: 549300EAQH74YHD07T53 | Long             | EC               | CORP              | SG        |      1394 | NS      | $30640.12     | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Luna Innovations Inc.                   | Luna Innovations Inc.                                      | CUSIP: 550351100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4366 | NS      | $29514.16     | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Inseego Corp.                           | Inseego Corp.                                              | CUSIP: 45782B104<br>LEI: 549300E27VG1NWGNA141 | Long             | EC               | CORP              | US        |      9183 | NS      | $11662.41     | 0.25%             |  |  |  | No            |                  1 | On Loan: No      |
| PDS Biotechnology Corp.                 | PDS Biotechnology Corp.                                    | CUSIP: 70465T107<br>LEI: 5493002KU8ACFTSMC935 | Long             | EC               | CORP              | US        |      5967 | NS      | $53882.01     | 1.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Integra LifeSciences Holdings Corp.     | Integra LifeSciences Holdings Corp.                        | CUSIP: 457985208<br>LEI: WB7IJCYY8YFTENS4O147 | Long             | EC               | CORP              | US        |       521 | NS      | $28623.74     | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Supernus Pharmaceuticals, Inc.          | Supernus Pharmaceuticals, Inc.                             | CUSIP: 868459108<br>LEI: 549300GRM36VBKISYJ58 | Long             | EC               | CORP              | US        |       725 | NS      | $26622.00     | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| ImmunoGen, Inc.                         | ImmunoGen, Inc.                                            | CUSIP: 45253H101<br>LEI: 54930084U0R1OP766Y02 | Long             | EC               | CORP              | US        |      4269 | NS      | $22156.11     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| AeroVironment, Inc.                     | AeroVironment, Inc.                                        | CUSIP: 008073108<br>LEI: 529900PGHVI29YLZ6221 | Long             | EC               | CORP              | US        |       278 | NS      | $25573.22     | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Paratek Pharmaceuticals, Inc.           | Paratek Pharmaceuticals, Inc.                              | CUSIP: 699374302<br>LEI: 5493007V5QDIWECEYV79 | Long             | EC               | CORP              | US        |      9875 | NS      | $21922.50     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Impinj, Inc.                            | Impinj, Inc.                                               | CUSIP: 453204109<br>LEI: 549300M26VGKSMMWWN17 | Long             | EC               | CORP              | US        |       277 | NS      | $35331.35     | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Mersana Therapeutics, Inc.              | Mersana Therapeutics, Inc.                                 | CUSIP: 59045L106<br>LEI: 529900VWD5VDZ7PVOS22 | Long             | EC               | CORP              | US        |      3302 | NS      | $21991.32     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Altimmune, Inc.                         | Altimmune, Inc.                                            | CUSIP: 02155H200<br>LEI: 549300EOYCQ8SW3NVE64 | Long             | EC               | CORP              | US        |      1123 | NS      | $11173.85     | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Adaptimmune Therapeutics PLC            | Adaptimmune Therapeutics PLC, ADR                          | CUSIP: 00653A107<br>LEI: 549300UUNWK8TRT5EW12 | Long             | EC               | CORP              | GB        |     12660 | NS      | $27472.20     | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| EchoStar Corp.                          | EchoStar Corp., Class A                                    | CUSIP: 278768106<br>LEI: 549300EE20907QZ9GT38 | Long             | EC               | CORP              | US        |      1346 | NS      | $23420.40     | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Allot Ltd.                              | Allot Ltd.                                                 | CUSIP: M0854Q105<br>LEI: 5493008MLSB5KCVNRK06 | Long             | EC               | CORP              | IL        |      5461 | NS      | $20260.31     | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Brightcove Inc.                         | Brightcove Inc.                                            | CUSIP: 10921T101<br>LEI: 5493006VI8OCN44T4W47 | Long             | EC               | CORP              | US        |      3740 | NS      | $20682.20     | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Sorrento Therapeutics, Inc.             | Sorrento Therapeutics, Inc.                                | CUSIP: 83587F202<br>LEI: 549300RH23PRR3M13410 | Long             | EC               | CORP              | US        |     12073 | NS      | $15694.90     | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Verint Systems Inc.                     | Verint Systems Inc.                                        | CUSIP: 92343X100<br>LEI: 549300KEQJS5FRVUCO94 | Long             | EC               | CORP              | US        |       511 | NS      | $20097.63     | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Surface Oncology, Inc.                  | Surface Oncology, Inc.                                     | CUSIP: 86877M209<br>LEI: 549300FCSG6MNIMFH738 | Long             | EC               | CORP              | US        |     18223 | NS      | $16765.16     | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Nordson Corp.                           | Nordson Corp.                                              | CUSIP: 655663102<br>LEI: 14OS6Q5N55N95WM84M53 | Long             | EC               | CORP              | US        |       108 | NS      | $25540.92     | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Quantum Corp.                           | Quantum Corp.                                              | CUSIP: 747906501<br>LEI: 5493007210175UIK7S88 | Long             | EC               | CORP              | US        |     15798 | NS      | $20063.46     | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| G1 Therapeutics, Inc.                   | G1 Therapeutics, Inc.                                      | CUSIP: 3621LQ109<br>LEI: 529900TC35UPZQYRKW13 | Long             | EC               | CORP              | US        |      1704 | NS      | $10155.84     | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| nLight, Inc.                            | nLight, Inc.                                               | CUSIP: 65487K100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1984 | NS      | $21546.24     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Bel Fuse Inc.                           | Bel Fuse Inc., Class B                                     | CUSIP: 077347300<br>LEI: 2549009L4XYDBRRY6X39 | Long             | EC               | CORP              | US        |       882 | NS      | $30376.08     | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Cara Therapeutics, Inc.                 | Cara Therapeutics, Inc.                                    | CUSIP: 140755109<br>LEI: 549300COVOY41P0GZ881 | Long             | EC               | CORP              | US        |      2402 | NS      | $28343.60     | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Digimarc Corp.                          | Digimarc Corp.                                             | CUSIP: 25381B101<br>LEI: 254900TL728B5T0M5R41 | Long             | EC               | CORP              | US        |      1406 | NS      | $31325.68     | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| SIGA Technologies, Inc.                 | SIGA Technologies, Inc.                                    | CUSIP: 826917106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1643 | NS      | $15082.74     | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Liquidia Corp.                          | Liquidia Corp.                                             | CUSIP: 53635D202<br>LEI: 549300O826O5VQJTG707 | Long             | EC               | CORP              | US        |      4291 | NS      | $21540.82     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| IGM Biosciences, Inc.                   | IGM Biosciences, Inc.                                      | CUSIP: 449585108<br>LEI: 5493008XCQES2N0VY969 | Long             | EC               | CORP              | US        |      1277 | NS      | $28106.77     | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Agenus Inc.                             | Agenus Inc.                                                | CUSIP: 00847G705<br>LEI: 529900NDQQGU5H4UJK81 | Long             | EC               | CORP              | US        |      9196 | NS      | $24829.20     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| KalVista Pharmaceuticals, Inc.          | KalVista Pharmaceuticals, Inc.                             | CUSIP: 483497103<br>LEI: 529900Q7IDA3WUGRZA51 | Long             | EC               | CORP              | US        |      1550 | NS      | $8354.50      | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Innoviva, Inc.                          | Innoviva, Inc.                                             | CUSIP: 45781M101<br>LEI: 549300ACOX4QTBES6535 | Long             | EC               | CORP              | US        |      1886 | NS      | $24763.18     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Personalis, Inc.                        | Personalis, Inc.                                           | CUSIP: 71535D106<br>LEI: 549300EZ2NYFK7H0US48 | Long             | EC               | CORP              | US        |      7485 | NS      | $19011.90     | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Netgear, Inc.                           | Netgear, Inc.                                              | CUSIP: 64111Q104<br>LEI: 54930067KX3UNRHDWA78 | Long             | EC               | CORP              | US        |      1067 | NS      | $21051.91     | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Alphatec Holdings, Inc.                 | Alphatec Holdings, Inc.                                    | CUSIP: 02081G201<br>LEI: 549300EZE8CQ8K65FS24 | Long             | EC               | CORP              | US        |      3302 | NS      | $33878.52     | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Baker Hughes Co.                        | Baker Hughes Co., Class A                                  | CUSIP: 05722G100<br>LEI: 549300XU3XH6F05YEQ93 | Long             | EC               | CORP              | US        |       984 | NS      | $28555.68     | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| BRP Inc.                                | BRP Inc.                                                   | CUSIP: 05577W200<br>LEI: 529900EPQGESIRCPY551 | Long             | EC               | CORP              | CA        |       362 | NS      | $27088.46     | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Everspin Technologies, Inc.             | Everspin Technologies, Inc.                                | CUSIP: 30041T104<br>LEI: 549300MNDRV7X6PEDF15 | Long             | EC               | CORP              | US        |      3398 | NS      | $22970.48     | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Aldeyra Therapeutics, Inc.              | Aldeyra Therapeutics, Inc.                                 | CUSIP: 01438T106<br>LEI: 529900HGKY864E4Y9014 | Long             | EC               | CORP              | US        |      3517 | NS      | $19695.20     | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Veeco Instruments Inc.                  | Veeco Instruments Inc.                                     | CUSIP: 922417100<br>LEI: 5493004201F72ADDZW04 | Long             | EC               | CORP              | US        |      1172 | NS      | $23299.36     | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| OSI Systems, Inc.                       | OSI Systems, Inc.                                          | CUSIP: 671044105<br>LEI: DDX3MPX1Y8YD30050X33 | Long             | EC               | CORP              | US        |       301 | NS      | $26632.48     | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Omeros Corp.                            | Omeros Corp.                                               | CUSIP: 682143102<br>LEI: 549300CJWLXX2MXVVV71 | Long             | EC               | CORP              | US        |      6150 | NS      | $13161.00     | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Commvault Systems, Inc.                 | Commvault Systems, Inc.                                    | CUSIP: 204166102<br>LEI: 65T5VRP62VXG39YFML83 | Long             | EC               | CORP              | US        |       457 | NS      | $30162.00     | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Anika Therapeutics, Inc.                | Anika Therapeutics, Inc.                                   | CUSIP: 035255108<br>LEI: 529900R9LS3Z0O6QH455 | Long             | EC               | CORP              | US        |      1108 | NS      | $34946.32     | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| CTI BioPharma Corp.                     | CTI BioPharma Corp.                                        | CUSIP: 12648L601<br>LEI: 549300RJTND7CT8R8853 | Long             | EC               | CORP              | US        |      3946 | NS      | $23754.92     | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| CytomX Therapeutics, Inc.               | CytomX Therapeutics, Inc.                                  | CUSIP: 23284F105<br>LEI: 5493004VW2FW0QLL3345 | Long             | EC               | CORP              | US        |     16738 | NS      | $29124.12     | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Cirrus Logic, Inc.                      | Cirrus Logic, Inc.                                         | CUSIP: 172755100<br>LEI: 549300NKSJEM5ZZSSV18 | Long             | EC               | CORP              | US        |       323 | NS      | $24131.33     | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Weatherford International PLC           | Weatherford International PLC                              | CUSIP: G48833118<br>LEI: 529900LPBDSCQDJKHQ39 | Long             | EC               | CORP              | IE        |       889 | NS      | $38582.60     | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| ChromaDex Corp.                         | ChromaDex Corp.                                            | CUSIP: 171077407<br>LEI: 529900OPI7B8JPXCVS70 | Long             | EC               | CORP              | US        |     17241 | NS      | $29654.52     | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| NGM Biopharmaceuticals, Inc.            | NGM Biopharmaceuticals, Inc.                               | CUSIP: 62921N105<br>LEI: 5493008V5DSDZIGQOP17 | Long             | EC               | CORP              | US        |      1803 | NS      | $9970.59      | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Arbutus Biopharma Corp.                 | Arbutus Biopharma Corp.                                    | CUSIP: 03879J100<br>LEI: 25490064CESONAUIAS23 | Long             | EC               | CORP              | CA        |     11186 | NS      | $26287.10     | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Voyager Therapeutics, Inc.              | Voyager Therapeutics, Inc.                                 | CUSIP: 92915B106<br>LEI: 54930082S4XVR0ZWCC74 | Long             | EC               | CORP              | US        |      4162 | NS      | $24722.28     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Ribbon Communications Inc.              | Ribbon Communications Inc.                                 | CUSIP: 762544104<br>LEI: 549300L1E8Z8RL7CUL52 | Long             | EC               | CORP              | US        |      7068 | NS      | $17882.04     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Rambus Inc.                             | Rambus Inc.                                                | CUSIP: 750917106<br>LEI: 2549000211GDCQSLV833 | Long             | EC               | CORP              | US        |       965 | NS      | $37036.70     | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Aclaris Therapeutics, Inc.              | Aclaris Therapeutics, Inc.                                 | CUSIP: 00461U105<br>LEI: 5493000B2LQ9QTW1DF52 | Long             | EC               | CORP              | US        |      1561 | NS      | $23758.42     | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| FARO Technologies, Inc.                 | FARO Technologies, Inc.                                    | CUSIP: 311642102<br>LEI: 529900MFEFNOFP3YR823 | Long             | EC               | CORP              | US        |       748 | NS      | $22380.16     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Inovio Pharmaceuticals, Inc.            | Inovio Pharmaceuticals, Inc.                               | CUSIP: 45773H201<br>LEI: 529900B9W875XDZXTM97 | Long             | EC               | CORP              | US        |     10828 | NS      | $22089.12     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| MicroVision, Inc.                       | MicroVision, Inc.                                          | CUSIP: 594960304<br>LEI: 5299001A8NIHHA9KOY43 | Long             | EC               | CORP              | US        |      5123 | NS      | $15522.69     | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Himax Technologies, Inc.                | Himax Technologies, Inc., ADR                              | CUSIP: 43289P106<br>LEI: 529900Z6XWS79D8T1X09 | Long             | EC               | CORP              | KY        |      4024 | NS      | $29656.88     | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| MaxLinear, Inc.                         | MaxLinear, Inc.                                            | CUSIP: 57776J100<br>LEI: 549300EMOI0SM2IY4F64 | Long             | EC               | CORP              | US        |       691 | NS      | $25290.60     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Concert Pharmaceuticals, Inc.           | Concert Pharmaceuticals, Inc.                              | CUSIP: 206022105<br>LEI: 529900PYI5BSGQNATP82 | Long             | EC               | CORP              | US        |      3762 | NS      | $18132.84     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| MiMedx Group, Inc.                      | MiMedx Group, Inc.                                         | CUSIP: 602496101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7023 | NS      | $22824.75     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| AngioDynamics, Inc.                     | AngioDynamics, Inc.                                        | CUSIP: 03475V101<br>LEI: 549300W3VKC5ZKMO8C28 | Long             | EC               | CORP              | US        |      1119 | NS      | $14491.05     | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Westport Fuel Systems Inc.              | Westport Fuel Systems Inc.                                 | CUSIP: 960908309<br>LEI: 549300ZBKJ4TMPXRB502 | Long             | EC               | CORP              | CA        |     22757 | NS      | $21844.44     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| iRobot Corp.                            | iRobot Corp.                                               | CUSIP: 462726100<br>LEI: 5493009PRNKOUKBAT390 | Long             | EC               | CORP              | US        |       422 | NS      | $21981.98     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| OmniAb, Inc.                            | OmniAb, Inc.                                               | CUSIP: 68218J202<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |        83 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Albireo Pharma, Inc.                    | Albireo Pharma, Inc.                                       | CUSIP: 01345P106<br>LEI: 549300835H8LC7O8VC29 | Long             | EC               | CORP              | US        |      1431 | NS      | $31596.48     | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2022-12-30

**Name of Applicant:** Invesco Exchange-Traded Fund Trust II

**Signature:** Sheri Morris

**Name of Signer:** Sheri Morris

**Title:** Vice President